ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, ELECTRONIC APPARATUS, AND ELECTRONIC EQUIPMENT
20260013391 ยท 2026-01-08
Assignee
Inventors
- Chanseok Oh (Yongin-si, KR)
- Sujin Shin (Yongin-si, KR)
- Seihwan Ahn (Yongin-si, KR)
- Sooinn Lee (Yongin-si, KR)
- Jaesung Lee (Yongin-si, KR)
- Mina Jeon (Yongin-si, KR)
Cpc classification
C09K2211/185
CHEMISTRY; METALLURGY
C09K2211/1044
CHEMISTRY; METALLURGY
C09K2211/1029
CHEMISTRY; METALLURGY
C09K2211/1014
CHEMISTRY; METALLURGY
C09K2211/1022
CHEMISTRY; METALLURGY
International classification
Abstract
Embodiments provide an organometallic compound, a light-emitting device including the organometallic compound, an electronic apparatus including the light-emitting device, and electronic equipment including the light-emitting device. The light-emitting device includes a first electrode, a second electrode facing the first electrode, an interlayer between the first electrode and the second electrode, and the organometallic compound. The organometallic compound is represented by Formula 1, which is explained in the specification:
##STR00001##
Claims
1. A light-emitting device comprising: a first electrode; a second electrode facing the first electrode; and an interlayer between the first electrode and the second electrode and comprising an emission layer; and an organometallic compound represented by Formula 1: ##STR00237## wherein in Formula 1, M is platinum (Pt), palladium (Pd), copper (Cu), silver (Ag), gold (Au), rhodium (Rh), ruthenium (Ru), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), or thulium (Tm), X.sub.1 to X.sub.4 are each independently C or N, Y.sub.3 to Y.sub.5 are each independently C or N, T.sub.3 and T.sub.5 are each independently C(R.sub.6), Si(R.sub.6), N, or P, ring CY.sub.1, ring CY.sub.2, ring CY.sub.31, ring CY.sub.32, ring CY.sub.4, ring CY.sub.51, and ring CY.sub.52 are each independently a C.sub.5-C.sub.30 carbocyclic group or a C.sub.1-C.sub.30 heterocyclic group, L.sub.1 and L.sub.2 are each independently a single bond, *O*, *S*, *C(R.sub.7)(R.sub.8)*, *C(R.sub.7)*, *C(R.sub.7)*, *C(R.sub.7)C(R.sub.7)*, *C(O)*, *C(S)*, *CC*, *B(R.sub.7)*, *N(R.sub.7)*, *P(R.sub.7)*, *Si(R.sub.7)(R.sub.8)*, *P(R.sub.7)(R.sub.8)*, or *Ge(R.sub.7)(R.sub.8)*, a1 and a2 are each independently an integer from 1 to 3, R.sub.1 to R.sub.8 are each independently hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group that is unsubstituted or substituted with at least one R.sub.10a, C(Q.sub.1)(Q.sub.2)(Q.sub.3), Si(Q.sub.1)(Q.sub.2)(Q.sub.3), N(Q.sub.1)(Q.sub.2), B(Q.sub.1)(Q.sub.2), C(O)(Q.sub.1), S(O).sub.2(Q.sub.1), or P(O)(Q.sub.1)(Q.sub.2), n1 to n5 are each independently an integer from 1 to 20, two or more neighboring groups selected from R.sub.1 to R.sub.8 are optionally bonded to each other to form a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, R.sub.10a is: hydrogen, F, Cl, Br, I, a hydroxyl group, a cyano group, or a nitro group; a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, Si(Q.sub.11)(Q.sub.12)(Q.sub.13), N(Q.sub.11)(Q.sub.12), B(Q.sub.11)(Q.sub.12), C(O)(Q.sub.11), S(O).sub.2(Q.sub.11), P(O)(Q.sub.11)(Q.sub.12), or a combination thereof; a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, or a C.sub.6-C.sub.60 arylthio group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, Si(Q.sub.21)(Q.sub.22)(Q.sub.23), N(Q.sub.21)(Q.sub.22), B(Q.sub.21)(Q.sub.22), C(O)(Q.sub.21), S(O).sub.2(Q.sub.21), P(O)(Q.sub.21)(Q.sub.22), or a combination thereof; or Si(Q.sub.31)(Q.sub.32)(Q.sub.33), N(Q.sub.31)(Q.sub.32), B(Q.sub.31)(Q.sub.32), C(O)(Q.sub.31), S(O).sub.2(Q.sub.31), or P(O)(Q.sub.31)(Q.sub.32), Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 are each independently: hydrogen; deuterium; F; Cl; Br; I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group; a C.sub.2-C.sub.60 alkenyl group; a C.sub.2-C.sub.60 alkynyl group; a C.sub.1-C.sub.60 alkoxy group; or a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or a combination thereof, and * and * each indicate a binding site to a neighboring atom.
2. The light-emitting device of claim 1, wherein the first electrode is an anode, the second electrode is a cathode, the interlayer further comprises: a hole transport region between the first electrode and the emission layer; and an electron transport region between the emission layer and the second electrode, the hole transport region comprises a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or a combination thereof, and the electron transport region comprises a hole blocking layer, an electron transport layer, an electron injection layer, an electron control layer, or a combination thereof.
3. The light-emitting device of claim 1, wherein the emission layer comprises a host and a dopant, and the dopant comprises the organometallic compound represented by Formula 1.
4. The light-emitting device of claim 3, wherein the host comprises a hole-transporting host, an electron-transporting host, or a combination thereof.
5. The light-emitting device of claim 3, wherein the dopant further comprises a delayed fluorescence material.
6. The light-emitting device of claim 1, wherein the emission layer emits fluorescent or phosphorescent blue light.
7. An electronic apparatus comprising the light-emitting device of claim 1.
8. The electronic apparatus of claim 7, further comprising: a thin-film transistor, wherein the thin-film transistor comprises a source electrode and a drain electrode, and the first electrode of the light-emitting device is electrically connected to the source electrode or the drain electrode.
9. The electronic apparatus of claim 7, further comprising: a color filter, a color conversion layer, a touch screen layer, a polarizing layer, or a combination thereof.
10. An electronic equipment comprising the light-emitting device of claim 1, wherein the electronic equipment is a flat panel display, a curved display, a computer monitor, a medical monitor, a television, an advertisement board, an indoor light, an outdoor light, a signal light, a head-up display, a fully transparent display, a partially transparent display, a flexible display, a rollable display, a foldable display, a stretchable display, a laser printer, a telephone, a mobile phone, a tablet computer, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a microdisplay, a three-dimensional (3D) display, a virtual reality display, an augmented reality display, a vehicle, a video wall with multiple displays tiled together, a theater screen, a stadium screen, a phototherapy device, or a signboard.
11. An organometallic compound represented by Formula 1: ##STR00238## wherein in Formula 1, M is platinum (Pt), palladium (Pd), copper (Cu), silver (Ag), gold (Au), rhodium (Rh), ruthenium (Ru), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), or thulium (Tm), X.sub.1 to X.sub.4 are each independently C or N, Y.sub.3 to Y.sub.5 are each independently C or N, T.sub.3 and T.sub.5 are each independently C(R.sub.6), Si(R.sub.6), N, or P, ring CY.sub.1, ring CY.sub.2, ring CY.sub.31, ring CY.sub.32, ring CY.sub.4, ring CY.sub.51, and ring CY.sub.52 are each independently a C.sub.5-C.sub.30 carbocyclic group or a C.sub.1-C.sub.30 heterocyclic group, L.sub.1 and L.sub.2 are each independently a single bond, *O*, *S*, *C(R.sub.7)(R.sub.8)*, *C(R.sub.7)*, *C(R.sub.7)*, *C(R.sub.7)C(R.sub.7)*, *C(O)*, *C(S)*, *CC*, *B(R.sub.7)*, *N(R.sub.7)*, *P(R.sub.7)*, *Si(R.sub.7)(R.sub.8)*, *P(R.sub.7)(R.sub.8)*, or *Ge(R.sub.7)(R.sub.8)*, a1 and a2 are each independently an integer from 1 to 3, R.sub.1 to R.sub.8 are each independently hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group that is unsubstituted or substituted with at least one R.sub.10a, C(Q.sub.1)(Q.sub.2)(Q.sub.3), Si(Q.sub.1)(Q.sub.2)(Q.sub.3), N(Q.sub.1)(Q.sub.2), B(Q.sub.1)(Q.sub.2), C(O)(Q.sub.1), S(O).sub.2(Q.sub.1), or P(O)(Q.sub.1)(Q.sub.2), n1 to n5 are each independently an integer from 1 to 20, two or more neighboring groups selected from R.sub.1 to R.sub.8 are optionally bonded to each other to form a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, R.sub.10a is: hydrogen, F, Cl, Br, I, a hydroxyl group, a cyano group, or a nitro group; a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, Si(Q.sub.11)(Q.sub.12)(Q.sub.13), N(Q.sub.11)(Q.sub.12), B(Q.sub.11)(Q.sub.12), C(O)(Q.sub.11), S(O).sub.2(Q.sub.11), P(O)(Q.sub.11)(Q.sub.12), or a combination thereof; a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, or a C.sub.6-C.sub.60 arylthio group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, Si(Q.sub.21)(Q.sub.22)(Q.sub.23), N(Q.sub.21)(Q.sub.22), B(Q.sub.21)(Q.sub.22), C(O)(Q.sub.21), S(O).sub.2(Q.sub.21), P(O)(Q.sub.21)(Q.sub.22), or a combination thereof; or Si(Q.sub.31)(Q.sub.32)(Q.sub.33), N(Q.sub.31)(Q.sub.32), B(Q.sub.31)(Q.sub.32), C(O)(Q.sub.31), S(O).sub.2(Q.sub.31), or P(O)(Q.sub.31)(Q.sub.32), Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 are each independently: hydrogen; deuterium; F; Cl; Br; I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group; a C.sub.2-C.sub.60 alkenyl group; a C.sub.2-C.sub.60 alkynyl group; a C.sub.1-C.sub.60 alkoxy group; or a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or a combination thereof, and * and * each indicate a binding site to a neighboring atom.
12. The organometallic compound of claim 11, wherein the organometallic compound represented by Formula 1 has a twist angle in a range of about 20 degrees to about 40 degrees.
13. The organometallic compound of claim 11, wherein X.sub.1 to X.sub.3 are each C, X.sub.4 is N, a bond between X.sub.1 and M and a bond between X.sub.4 and M are each a coordinate bond, and a bond between X.sub.2 and M and a bond between X.sub.3 and M are each a covalent bond.
14. The organometallic compound of claim 11, wherein in Formula 1, a moiety represented by ##STR00239## is a moiety represented by one of Formulae CY1A to CY1E: ##STR00240## wherein in Formulae CY1A to CY1E, R.sub.11 is a terphenyl group that is unsubstituted or substituted with at least one R.sub.10a, R.sub.10a is the same as described in Formula 1, X.sub.11 is N or C(R.sub.11), X.sub.12 is N or C(R.sub.12), X.sub.13 is N or C(R.sub.13), X.sub.14 is N or C(R.sub.14), X.sub.15 is N or C(R.sub.15), X.sub.16 is N or C(R.sub.16), X.sub.17 is N or C(R.sub.17), R.sub.12 to R.sub.17 are each independently the same as described in connection with R.sub.1 in Formula 1, and * and * each indicate a binding site to a neighboring atom.
15. The organometallic compound of claim 11, wherein in Formula 1, a moiety represented by ##STR00241## is a moiety represented by one of Formulae CY1A-1, CY1B-1, and CY1B-2: ##STR00242## wherein in Formulae CY1A-1, CY1B-1, and CY1B-2, X.sub.11 is N or C(R.sub.11), X.sub.12 is N or C(R.sub.12), X.sub.13 is N or C(R.sub.13), X.sub.14 is N or C(R.sub.14), R.sub.11 to R.sub.14 are each independently the same as described in connection with R.sub.1 in Formula 1, Z.sub.11 to Z.sub.16 are each independently the same as described in connection with R.sub.10a in Formula 1, b11 and b13 are each independently an integer from 0 to 5, b12 is an integer from 0 to 3, b14 to b16 are each independently an integer from 0 to 4, and * and * each indicate a binding site to a neighboring atom.
16. The organometallic compound of claim 15, wherein in Formulae CY1A-1 and CYB-1, the left and right sides of a moiety represented by ##STR00243## are asymmetric with respect to a central phenylene group.
17. The organometallic compound of claim 11, wherein T.sub.3 and T.sub.5 are each N, Y.sub.3 and Y.sub.5 are each C, and Y.sub.4 is C or N.
18. The organometallic compound of claim 11, wherein the organometallic compound is represented by Formula 1-1: ##STR00244## wherein in Formula 1-1, M, X.sub.1, X.sub.2, Y.sub.4, ring CY.sub.1, ring CY.sub.2, L.sub.1, L.sub.2, a1, a2, R.sub.1, R.sub.2, n1, and n2 are each the same as described in Formula 1, X.sub.31 is C(R.sub.31) or N, X.sub.32 is C(R.sub.32) or N, X.sub.33 is C(R.sub.33) or N, X.sub.34 is C(R.sub.34) or N, X.sub.35 is C(R.sub.35) or N, X.sub.42 is C(R.sub.42) or N, X.sub.51 is C(R.sub.51) or N, X.sub.52 is C(R.sub.52) or N, X.sub.53 is C(R.sub.53) or N, X.sub.54 is C(R.sub.54) or N, X.sub.55 is C(R.sub.55) or N, X.sub.56 is C(R.sub.56) or N, X.sub.57 is C(R.sub.57) or N, R.sub.31 to R.sub.35 are each independently the same as described in connection with R.sub.3 in Formula 1, R.sub.42 is the same as described in connection with R.sub.4 in Formula 1, and R.sub.51 to R.sub.57 are each independently the same as described in connection with R.sub.5 in Formula 1.
19. The organometallic compound of claim 11, wherein the organometallic compound comprises at least one deuterium.
20. The organometallic compound of claim 11, wherein the organometallic compound is one of Compounds 1 to 96: ##STR00245## ##STR00246## ##STR00247## ##STR00248## ##STR00249## ##STR00250## ##STR00251## ##STR00252## ##STR00253## ##STR00254## ##STR00255## ##STR00256## ##STR00257##
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0051] The accompanying drawings are included to provide a further understanding of the embodiments, and are incorporated in and constitute a part of this specification.
[0052] The drawings illustrate embodiments of the disclosure and principles thereof. The above and other aspects and features of the disclosure will become more apparent by describing in detail embodiments thereof with reference to the accompanying drawings, in which:
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
DETAILED DESCRIPTION OF THE EMBODIMENTS
[0059] The disclosure will now be described more fully hereinafter with reference to the accompanying drawings, in which embodiments are shown. This disclosure may, however, be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the disclosure to those skilled in the art.
[0060] In the drawings, the sizes, thicknesses, ratios, and dimensions of the elements may be exaggerated for ease of description and for clarity. Like reference numbers and/or like reference characters refer to like elements throughout.
[0061] In the description, it will be understood that when an element (or region, layer, part, etc.) is referred to as being on, connected to, or coupled to another element, it can be directly on, connected to, or coupled to the other element, or one or more intervening elements may be present therebetween. In a similar sense, when an element (or region, layer, part, etc.) is described as covering another element, it can directly cover the other element, or one or more intervening elements may be present therebetween.
[0062] In the description, when an element is directly on, directly connected to, or directly coupled to another element, there are no intervening elements present. For example, directly on may mean that two layers or two elements are disposed without an additional element such as an adhesion element therebetween.
[0063] As used herein, the singular forms a, an, and the are intended to include the plural forms as well, unless the context clearly indicates otherwise.
[0064] As used herein, the term and/or includes any and all combinations of one or more of the associated listed items. For example, A and/or B may be understood to mean A, B, or A and B. The terms and and or may be used in the conjunctive or disjunctive sense and may be understood to be equivalent to and/or.
[0065] In the specification and the claims, the term at least one of is intended to include the meaning of at least one selected from the group consisting of for the purpose of its meaning and interpretation. For example, at least one of A, B, and C may be understood to mean A only, B only, C only, or any combination of two or more of A, B, and C, such as ABC, ACC, BC, or CC. When preceding a list of elements, the term, at least one of, modifies the entire list of elements and does not modify the individual elements of the list.
[0066] It will be understood that, although the terms first, second, etc. may be used herein to describe various elements, these elements should not be limited by these terms. These terms are only used to distinguish one element from another element. Thus, a first element could be termed a second element without departing from the teachings of the disclosure. Similarly, a second element could be termed a first element, without departing from the scope of the disclosure.
[0067] The spatially relative terms below, beneath, lower, above, upper, or the like, may be used herein for ease of description to describe the relations between one element or component and another element or component as illustrated in the drawings. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation, in addition to the orientation depicted in the drawings. For example, in the case where a device illustrated in the drawing is turned over, the device positioned below or beneath another device may be placed above another device. Accordingly, the illustrative term below may include both the lower and upper positions. The device may also be oriented in other directions and thus the spatially relative terms may be interpreted differently depending on the orientations.
[0068] The terms about or approximately as used herein is inclusive of the stated value and means within an acceptable range of deviation for the recited value as determined by one of ordinary skill in the art, considering the measurement in question and the error associated with measurement of the recited quantity (for example, the limitations of the measurement system). For example, about may mean within one or more standard deviations, or within 20%, 10%, or 5% of the stated value.
[0069] It should be understood that the terms comprises, comprising, includes, including, have, having, contains, containing, and the like are intended to specify the presence of stated features, integers, steps, operations, elements, components, or combinations thereof in the disclosure, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, or combinations thereof.
[0070] Unless otherwise defined or implied herein, all terms (including technical and scientific terms) used have the same meaning as commonly understood by those skilled in the art to which this disclosure pertains. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and should not be interpreted in an ideal or excessively formal sense unless clearly defined in the specification.
[0071] According to an embodiment, a light-emitting device (for example, an organic light-emitting device) may include: a first electrode; a second electrode facing the first electrode; an interlayer between the first electrode and the second electrode and including an emission layer; and an organometallic compound represented by Formula 1.
[0072] The organometallic compound may be represented by Formula 1:
##STR00006##
[0073] In Formula 1, M may be platinum (Pt), palladium (Pd), copper (Cu), silver (Ag), gold (Au), rhodium (Rh), ruthenium (Ru), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), or thulium (Tm).
[0074] In an embodiment, M may be platinum (Pt) or palladium (Pd).
[0075] In Formula 1, X.sub.1 to X.sub.4 may each independently be C or N.
[0076] In an embodiment, X.sub.1 to X.sub.3 may each be C, and X.sub.4 may be N.
[0077] In an embodiment, a bond between X.sub.1 and M and a bond between X.sub.4 and M may each be a coordinate bond, and a bond between X.sub.2 and M and a bond between X.sub.3 and M may each be a covalent bond.
[0078] In Formula 1, Y.sub.3 to Y.sub.5 may each independently be C or N.
[0079] In an embodiment, Y.sub.3 and Y.sub.5 may each be C, and Y.sub.4 may be C or N. In an embodiment, Y.sub.4 may be C.
[0080] In Formula 1, T.sub.3 and T.sub.5 may each independently be C(R.sub.6), Si(R.sub.6), N, or P.
[0081] In an embodiment, T.sub.3 and T.sub.5 may each be N.
[0082] In Formula 1, ring CY.sub.1, ring CY.sub.2, ring CY.sub.31, ring CY.sub.32, ring CY.sub.4, ring CY.sub.51, and ring CY.sub.52 may each independently be a C.sub.5-C.sub.30 carbocyclic group or a C.sub.1-C.sub.30 heterocyclic group.
[0083] In an embodiment, ring CY.sub.1, ring CY.sub.2, ring CY.sub.31, ring CY.sub.32, ring CY.sub.4, ring CY.sub.51, and ring CY.sub.52 may each independently be a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentadiene group, a furan group, a thiophene group, a silole group, an indene group, a fluorene group, an indole group, a carbazole group, a benzofuran group, a dibenzofuran group, a benzothiophene group, a dibenzothiophene group, a benzosilole group, a dibenzosilole group, an azafluorene group, an azacarbazole group, an azadibenzofuran group, an azadibenzothiophene group, an azadibenzosilole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isooxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, a benzothiadiazole group, a dibenzooxasiline group, a dibenzothiasiline group, a dibenzodihydroazasiline group, a dibenzodihydrodihydrodisiline group, a dibenzodihydrosiline group, a dibenzodioxin group, a dibenzooxathiine group, a dibenzooxazine group, a dibenzopyran group, a dibenzodithiine group, a dibenzothiazine group, a dibenzothiopyran group, a dibenzocyclohexadiene group, a dibenzodihydropyridine group, or a dibenzodihydropyrazine group.
[0084] In an embodiment, in Formula 1, a moiety represented by
##STR00007##
may be a moiety represented by one of Formulae CY1A to CY1E:
##STR00008##
[0085] In Formulae CY1A to CY1E, [0086] R.sub.11 may be a terphenyl group that is unsubstituted or substituted with at least one R.sub.10a, [0087] R.sub.10a may be the same as described herein, [0088] X.sub.11 may be N or C(R.sub.11), X.sub.12 may be N or C(R.sub.12), X.sub.13 may be N or C(R.sub.13), X.sub.14 may be N or C(R.sub.14), X.sub.15 may be N or C(R.sub.15), X.sub.16 may be N or C(R.sub.16), and X.sub.17 may be N or C(R.sub.17), [0089] R.sub.12 to R.sub.17 may each independently be the same as described in connection with R.sub.1, and [0090] * and * each indicate a binding site to a neighboring atom.
[0091] In an embodiment, in Formula 1, a moiety represented by
##STR00009##
may be a moiety represented by one of Formulae CY1A-1, CY1B-1, and CY1B-2:
##STR00010##
[0092] In Formulae CY.sub.1A-1, CY1B-1, and CY.sub.1B-2,
[0093] X.sub.11 may be N or C(R.sub.11), X.sub.12 may be N or C(R.sub.12), X.sub.13 may be N or C(R.sub.13), and X.sub.14 may be N or C(R.sub.14), [0094] R.sub.11 to R.sub.14 may each independently be the same as described in connection with R.sub.1, [0095] Z.sub.11 to Z.sub.16 may each independently be the same as described in connection with R.sub.10a, [0096] b11 and b13 may each independently be an integer from 0 to 5, [0097] b12 may be an integer from 0 to 3, [0098] b14 to b16 may each independently be an integer from 0 to 4, and [0099] * and * each indicate a binding site to a neighboring atom.
[0100] In an embodiment, in Formulae CY1A-1 and CYB-1, the left and right sides of a moiety represented by
##STR00011##
may be asymmetric with respect to a central phenylene group.
[0101] In an embodiment, in Formula 1, a moiety represented by
##STR00012##
may be a moiety represented by one of Formulae CY2(1) to CY2(13):
##STR00013## ##STR00014##
[0102] In Formulae CY2(1) to CY2(13),
[0103] T.sub.21 may be B(Y.sub.21), C(Y.sub.21)(Y.sub.22), N(Y.sub.21), O, S, or Si(Y.sub.21)(Y.sub.22), [0104] T.sub.22 may be C(Y.sub.21), N, or Si(Y.sub.21), [0105] R.sub.21 to R.sub.26, Y.sub.21, and Y.sub.22 may each be the same as described in connection with R.sub.2, and [0106] *, *, and * each indicate a binding site to a neighboring atom.
[0107] In an embodiment, the organometallic compound represented by Formula 1 may be represented by Formula 1-1:
##STR00015##
[0108] In Formula 1-1, [0109] M, X.sub.1, X.sub.2, Y.sub.4, ring CY.sub.1, ring CY.sub.2, L.sub.1, L.sub.2, a1, a2, R.sub.1, R.sub.2, n1, and n2 may each be the same as described in the specification, [0110] X.sub.31 may be C(R.sub.31) or N, X.sub.32 may be C(R.sub.32) or N, X.sub.33 may be C(R.sub.33) or N, X.sub.34 may be C(R.sub.34) or N, and X.sub.35 may be C(R.sub.35) or N, [0111] X.sub.42 may be C(R.sub.42) or N, [0112] X.sub.51 may be C(R.sub.51) or N, X.sub.52 may be C(R.sub.52) or N, X.sub.53 may be C(R.sub.53) or N, X.sub.54 may be C(R.sub.54) or N, X.sub.55 may be C(R.sub.55) or N, X.sub.56 may be C(R.sub.56) or N, and X.sub.57 may be C(R.sub.57) or N, [0113] R.sub.31 to R.sub.35 may each independently be the same as described in connection with R.sub.3, [0114] R.sub.42 may be the same as described in connection with R.sub.4, and [0115] R.sub.51 to R.sub.57 may each independently be the same as described in connection with R.sub.5.
[0116] In Formula 1, L.sub.1 and L.sub.2 may each independently be a single bond, *O*, *S*, C(R.sub.7)(R.sub.8)*, *C(R.sub.7)*, *C(R.sub.7)*, *C(R.sub.7)C(R.sub.7)*, *C(O)*, *C(S)*, *CC*, B(R.sub.7)*, *N(R.sub.7)*, *P(R.sub.7)*, *Si(R.sub.7)(R.sub.8)*, *P(R.sub.7)(R.sub.8)*, or *Ge(R.sub.7)(R.sub.8)*.
[0117] In Formula 1, a1 and a2 respectively indicate the number of L.sub.1 and the number of L.sub.2, and a1 and a2 may each independently be an integer from 1 to 3. When a1 is 2 or more, two or more of L.sub.1 may be identical to or different from each other, and when a2 is 2 or more, two or more of L.sub.2 may be identical to or different from each other.
[0118] In an embodiment, L.sub.1 and L.sub.2 may each be a single bond.
[0119] In Formula 1, R.sub.1 to R.sub.8 may each independently be hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkylthio group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group that is unsubstituted or substituted with at least one R.sub.10a, C(Q.sub.1)(Q.sub.2)(Q.sub.3), Si(Q.sub.1)(Q.sub.2)(Q.sub.3), N(Q.sub.1)(Q.sub.2), B(Q.sub.1)(Q.sub.2), C(O)(Q.sub.1), S(O).sub.2(Q.sub.1), or P(O)(Q.sub.1)(Q.sub.2).
[0120] In Formula 1, n1, n2, n3, n4, and n5 respectively indicate the number of R.sub.1, the number of R.sub.2, the number of R.sub.3, the number of R.sub.4, and the number of R.sub.5, and n1 to n5 may each independently be an integer from 1 to 20. When n1 is 2 or more, two or more of R.sub.1 may be identical to or different from each other, when n2 is 2 or more, two or more of R.sub.2 may be identical to or different from each other, when n3 is 2 or more, two or more of R.sub.3 may be identical to or different from each other, when n4 is 2 or more, two or more of R.sub.4 may be identical to or different from each other, and when n5 is 2 or more, two or more of R.sub.5 may be identical to or different from each other.
[0121] In Formula 1, two or more neighboring groups selected from R.sub.1 to R.sub.8 may optionally be bonded to each other to form a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a.
[0122] In Formula 1, R.sub.10a may be: [0123] hydrogen, F, Cl, Br, I, a hydroxyl group, a cyano group, or a nitro group; [0124] a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, Si(Q.sub.11)(Q.sub.12)(Q.sub.13), N(Q.sub.11)(Q.sub.12), B(Q.sub.11)(Q.sub.12), C(O)(Q.sub.11), S(O).sub.2(Q.sub.11), P(O)(Q.sub.11)(Q.sub.12), or any combination thereof; [0125] a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, or a C.sub.6-C.sub.60 arylthio group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, Si(Q.sub.21)(Q.sub.22)(Q.sub.23), N(Q.sub.21)(Q.sub.22), B(Q.sub.21)(Q.sub.22), C(O)(Q.sub.21), S(O).sub.2(Q.sub.21), P(O)(Q.sub.21)(Q.sub.22), or any combination thereof; or [0126] Si(Q.sub.31)(Q.sub.32)(Q.sub.33), N(Q.sub.31)(Q.sub.32), B(Q.sub.31)(Q.sub.32), C(O)(Q.sub.31), S(O).sub.2(Q.sub.31), or P(O)(Q.sub.31)(Q.sub.32), and [0127] Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 may each independently be hydrogen; deuterium; F; Cl; Br; I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group; a C.sub.2-C.sub.60 alkenyl group; a C.sub.2-C.sub.60 alkynyl group; a C.sub.1-C.sub.60 alkoxy group; or a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.
[0128] In an embodiment, R.sub.1 to R.sub.8 may each independently be:
[0129] hydrogen, deuterium, F, a C.sub.1-C.sub.20 alkyl group, or a C.sub.1-C.sub.20 alkoxy group; [0130] a C.sub.1-C.sub.20 alkyl group or a C.sub.1-C.sub.20 alkoxy group, each substituted with deuterium, F, CD.sub.3, CD.sub.2H, CDH.sub.2, CF.sub.3, CF.sub.2H, CFH.sub.2, a C.sub.1-C.sub.10 alkyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a naphthyl group, a pyridinyl group, a pyrimidinyl group, or any combination thereof; [0131] a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.1 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, or a dibenzothiophenyl group, each unsubstituted or substituted with deuterium, F, CD.sub.3, CD.sub.2H, CDH.sub.2, CF.sub.3, CF.sub.2H, CFH.sub.2, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a biphenyl group, a C.sub.1-C.sub.1 alkylphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, a dibenzofuranyl group, a dibenzothiophenyl group, O(Q.sub.31), S(Q.sub.31), Si(Q.sub.31)(Q.sub.32)(Q.sub.33), N(Q.sub.31)(Q.sub.32), or any combination thereof; or [0132] C(Q.sub.1)(Q.sub.2)(Q.sub.3), Si(Q.sub.1)(Q.sub.2)(Q.sub.3), or N(Q.sub.1)(Q.sub.2), and [0133] Q.sub.1 to Q.sub.3 and Q.sub.31 to Q.sub.33 may each independently be: hydrogen; deuterium; F; a C.sub.1-C.sub.60 alkyl group; a C.sub.2-C.sub.60 alkenyl group; a C.sub.2-C.sub.60 alkynyl group; a C.sub.1-C.sub.60 alkoxy group; or a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, F, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.
[0134] * and * each indicate a binding site to a neighboring atom.
[0135] In an embodiment, the organometallic compound represented by Formula 1 may be selected from Compounds 1 to 96:
##STR00016## ##STR00017## ##STR00018## ##STR00019## ##STR00020## ##STR00021## ##STR00022## ##STR00023## ##STR00024## ##STR00025## ##STR00026## ##STR00027## ##STR00028## ##STR00029## ##STR00030## ##STR00031## ##STR00032## ##STR00033## ##STR00034## ##STR00035##
##STR00036##
[0136] In an embodiment, the organometallic compound represented by Formula 1 may have a twist angle in a range of about 15 degrees to about 50 degrees. For example, the twist angle may be in a range of about 20 degrees to about 45 degrees. For example, the twist angle may be in a range of about 20 degrees to about 40 degrees or in a range of about 25 degrees to about 40 degrees. In an embodiment, the organometallic compound represented by Formula 1 may have a twist angle in a range of about 28 degrees to about 35 degrees.
[0137] In the specification, the twist angle in Formula 1 refers to an angle formed between a plane A1 that includes ring CY.sub.1 and ring CY.sub.2 and a plane A2 that includes ring CY.sub.31 and ring CY.sub.4 (see Formula 1A).
##STR00037##
[0138] In the specification, the twist angle may be calculated using B3LYP/6-311g(d,p) based on quantum chemical calculations, and the twist angle may be calculated for the structure of an organometallic compound optimized in the singlet ground (S0) state.
[0139] In an embodiment, the organometallic compound represented by Formula 1 may emit phosphorescent or fluorescent blue light.
[0140] In an embodiment, the organometallic compound represented by Formula 1 may emit light having a maximum emission wavelength in a range of about 380 nm to about 495 nm. For example, the organometallic compound represented by Formula 1 may emit light having a maximum emission wavelength in a range of about 400 nm to about 490 nm. In an embodiment, the organometallic compound represented by Formula 1 may emit light having a maximum emission wavelength in a range of about 420 nm to about 485 nm. In an embodiment, the organometallic compound represented by Formula 1 may emit light having a maximum emission wavelength in a range of about 425 nm to about 480 nm. For example, the organometallic compound represented by Formula 1 may emit light having a maximum emission wavelength in a range of about 430 nm to about 475 nm or in a range about 440 nm to about 475 nm.
[0141] In an embodiment, the organometallic compound represented by Formula 1 may include at least one deuterium atom.
[0142] The organometallic compound represented by Formula 1 may have enhanced molecular rigidity by introducing boron (B) as a linking group at a specific position, and thus may have a small Stokes shift. Therefore, the material stability and photoluminescence quantum efficiency (PLQY) of the organometallic compound represented by Formula 1 may be improved. In cases where the organometallic compound represented by Formula 1 is used as a dopant in the emission layer, the organometallic compound may enable the manufacture of a light-emitting device with a long lifespan and high efficiency.
[0143] By introducing a carbene moiety substituted with a terphenyl group at ring CY.sub.1 of the organometallic compound represented by Formula 1, steric hindrance of a molecule may increase, thus increasing the distance between molecules and suppressing interaction between molecules. This may allow suppression of Dexter energy transfer of the organometallic compound represented by Formula 1, as well as the formation of an excimer or an exciplex. In cases where the organometallic compound represented by Formula 1 is used as a dopant in the emission layer, the organometallic compound may increase device stability, thereby enabling the manufacture of a light-emitting device with an extended lifespan.
[0144] In the organometallic compound represented by Formula 1, reverse intersystem crossing (RISC) or intersystem crossing may be further activated by incorporating thermally activated delayed fluorescence (TADF) properties into a Pt complex. Therefore, a Kr value of the organometallic compound represented by Formula 1 may increase, while a K.sub.nr value may be suppressed, leading to an increase in a photoluminescence quantum efficiency (PLQY). In cases where the organometallic compound is used as a dopant in the emission layer, the organometallic compound may enable the manufacture of a light-emitting device with high efficiency.
[0145] Synthesis methods for the organometallic compound represented by Formula 1 may be recognizable by one of ordinary skill in the art by referring to the Synthesis Examples and/or Examples provided below.
[0146] At least one organometallic compound represented by Formula 1 may be used in a light-emitting device (for example, an organic light-emitting device). Thus, according to an embodiment, a light-emitting device may include: a first electrode; a second electrode facing the first electrode; an interlayer between the first electrode and the second electrode and including an emission layer; and the organometallic compound represented by Formula 1 as described herein.
[0147] In an embodiment, the first electrode may be an anode, and the second electrode may be a cathode.
[0148] In an embodiment, the interlayer may further include a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode. The hole transport region may include a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof. The electron transport region may include a hole blocking layer, an electron transport layer, an electron injection layer, an electron control layer, or any combination thereof.
[0149] In an embodiment, the interlayer may include the organometallic compound represented by Formula 1.
[0150] In an embodiment, the emission layer may include the organometallic compound represented by Formula 1.
[0151] In an embodiment, the emission layer may include a host and a dopant, and the dopant may include the organometallic compound represented by Formula 1. For example, the organometallic compound represented by Formula 1 may serve as a light-emitting dopant or a non-light-emitting dopant.
[0152] In an embodiment, the amount of the host in the emission layer may be greater than the amount of the dopant.
[0153] In an embodiment, the host may include a first host compound, a second host compound, or any combination thereof. In an embodiment, the first host compound may be a hole-transporting host, and the second host compound may be an electron-transporting host.
[0154] In an embodiment, the first host compound and the second host compound may serve as an exciplex host.
[0155] In an embodiment, the first host compound may be represented by any one of Formulae 311-1 to 311-6, and the second host compound may be represented by any one of Formulae 312-1 to 312-4 and 313:
##STR00038## ##STR00039##
[0156] In Formulae 311-1 to 311-6, 312-1 to 312-4, 313, and 313A, [0157] Ar.sub.301 may be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0158] A.sub.301 to A.sub.304 may each independently be a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, [0159] X.sub.301 may be O, S, N[(L.sub.304).sub.xb4-R.sub.304], C[(L.sub.304).sub.xb4-R.sub.304][(L.sub.305).sub.xb5-R.sub.305], or Si[(L.sub.304).sub.xb4-R.sub.304][(L.sub.305).sub.xb5-R.sub.305], [0160] X.sub.302, Y.sub.301, and Y.sub.302 may each independently be a single bond, O, S, N[(L.sub.305).sub.xb5-R.sub.305], C[(L.sub.304).sub.xb4-R.sub.304][(L.sub.305).sub.xb5-R.sub.305], Si[(L.sub.304).sub.xb4-R.sub.304][(L.sub.305).sub.xb5-R.sub.305], or S(O).sub.2, [0161] xb1 to xb5 may each independently be 0, 1, 2, 3, 4, or 5, [0162] xb6 may be 1, 2, 3, 4, or 5, [0163] X.sub.321 to X.sub.328 may each independently be N or C[(L.sub.324).sub.xb24-R.sub.324], [0164] Y.sub.321 may be *O*, *S*, *N[(L.sub.325).sub.xb25-R.sub.325]*, *C[(L.sub.325).sub.xb25-R.sub.325][(L.sub.326).sub.xb26-R.sub.326]*, *C[(L.sub.325).sub.xb25-R.sub.325]C[(L.sub.326).sub.xb26-R.sub.326]*, *C[(L.sub.325).sub.xb25-R.sub.325]N*, or *NC[(L.sub.326).sub.xb26-R.sub.326]*, [0165] k21 may be 0, 1, or 2, wherein when k21 is 0, Y.sub.321 may not be present, [0166] xb21 to xb26 may each independently be 0, 1, 2, 3, 4, or 5, [0167] A.sub.31, A.sub.32, and A.sub.34 may each independently be a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.30 heterocyclic group, [0168] A.sub.33 may be a group represented by Formula 313A, [0169] X.sub.31 may be N[(L.sub.335).sub.xb35-(R.sub.335)], O, S, Se, C[(L.sub.335).sub.xb35-(R.sub.335)][(L.sub.336).sub.xb36-(R.sub.336)], or Si[(L.sub.335).sub.xb35-(R.sub.335)][(L.sub.336).sub.xb36-(R.sub.336)], [0170] xb31 to xb36 may each independently be 0, 1, 2, 3, 4, or 5, [0171] xb42 to xb44 may each independently be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10, [0172] L.sub.301 to L.sub.306, L.sub.321 to L.sub.326, and L.sub.331 to L.sub.336 may each independently be a single bond, a C.sub.1-C.sub.20 alkylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.20 alkenylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.20 alkynylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.10 cycloalkylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.10 heterocycloalkylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.10 cycloalkenylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.10 heterocycloalkenylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroarylene group that is unsubstituted or substituted with at least one R.sub.10a, a divalent non-aromatic condensed polycyclic group that is unsubstituted or substituted with at least one R.sub.10a, or a divalent non-aromatic condensed heteropolycyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0173] R.sub.301 to R.sub.305, R.sub.311 to R.sub.314, R.sub.321 to R.sub.326, and R.sub.331 to R.sub.336 may each independently be hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C.sub.1-C.sub.60 alkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.10 cycloalkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.10 heterocycloalkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.10 cycloalkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.10 heterocycloalkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 aryloxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.6-C.sub.60 arylthio group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroaryl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroaryloxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heteroarylthio group that is unsubstituted or substituted with at least one R.sub.10a, a monovalent non-aromatic condensed polycyclic group that is unsubstituted or substituted with at least one R.sub.10a, a monovalent non-aromatic condensed heteropolycyclic group that is unsubstituted or substituted with at least one R.sub.10a, Si(Q.sub.1)(Q.sub.2)(Q.sub.3), B(Q.sub.1)(Q.sub.2), N(Q.sub.1)(Q.sub.2), P(Q.sub.1)(Q.sub.2), C(O)(Q.sub.1), S(O)(Q.sub.1), S(O).sub.2(Q.sub.1), P(O)(Q.sub.1)(Q.sub.2), or P(S)(Q.sub.1)(Q.sub.2), [0174] two or more neighboring groups selected from R.sub.321 to R.sub.326 may optionally be bonded to each other to form a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0175] R.sub.10a may be: [0176] deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, or a nitro group; [0177] a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.1-C.sub.60 heteroaryloxy group, a C.sub.1-C.sub.60 heteroarylthio group, Si(Q.sub.11)(Q.sub.12)(Q.sub.13), N(Q.sub.11)(Q.sub.12), B(Q.sub.11)(Q.sub.12), C(O)(Q.sub.11), S(O).sub.2(Q.sub.11), P(O)(Q.sub.11)(Q.sub.12), or any combination thereof; [0178] a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.1-C.sub.60 heteroaryloxy group, or a C.sub.1-C.sub.60 heteroarylthio group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.1-C.sub.60 heteroaryloxy group, a C.sub.1-C.sub.60 heteroarylthio group, Si(Q.sub.21)(Q.sub.22)(Q.sub.23), N(Q.sub.21)(Q.sub.22), B(Q.sub.21)(Q.sub.22), C(O)(Q.sub.21), S(O).sub.2(Q.sub.21), P(O)(Q.sub.21)(Q.sub.22), or any combination thereof; or [0179] Si(Q.sub.31)(Q.sub.32)(Q.sub.33), N(Q.sub.31)(Q.sub.32), B(Q.sub.31)(Q.sub.32), C(O)(Q.sub.31), S(O).sub.2(Q.sub.31), or P(O)(Q.sub.31)(Q.sub.32), and [0180] Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 may each independently be: hydrogen; deuterium; F; Cl; Br; I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group; a C.sub.2-C.sub.60 alkenyl group; a C.sub.2-C.sub.60 alkynyl group; a C.sub.1-C.sub.60 alkoxy group; or a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.
[0181] In an embodiment, the first host compound may be one of Compounds HTH1 to HTH56 and HTH1 to HTH40, but the disclosure is not limited thereto.
##STR00040## ##STR00041## ##STR00042## ##STR00043## ##STR00044## ##STR00045## ##STR00046## ##STR00047## ##STR00048## ##STR00049## ##STR00050## ##STR00051## ##STR00052## ##STR00053## ##STR00054## ##STR00055## ##STR00056## ##STR00057## ##STR00058## ##STR00059## ##STR00060## ##STR00061## ##STR00062## ##STR00063##
[0182] In an embodiment, the second host compound may be one of Compounds ETH1 to ETH86 and ETH1 to ETH32, but the disclosure is not limited thereto.
##STR00064## ##STR00065## ##STR00066## ##STR00067## ##STR00068## ##STR00069## ##STR00070## ##STR00071## ##STR00072## ##STR00073## ##STR00074## ##STR00075## ##STR00076## ##STR00077## ##STR00078## ##STR00079## ##STR00080## ##STR00081## ##STR00082## ##STR00083## ##STR00084## ##STR00085## ##STR00086## ##STR00087## ##STR00088## ##STR00089## ##STR00090## ##STR00091## ##STR00092## ##STR00093##
[0183] In an embodiment, the emission layer may further include a delayed fluorescence material. For example, the dopant may further include a delayed fluorescence material.
[0184] In an embodiment, the delayed fluorescence material may be represented by Formula 701 or Formula 702:
##STR00094##
[0185] In Formulae 701 and 702, [0186] W.sub.a to W.sub.d may each independently be N(R.sub.701f), C(R.sub.701f)(R.sub.701g), O, or S, [0187] R.sub.701a to R.sub.701g may each independently be hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, C(Q.sub.1)(Q.sub.2)(Q.sub.3), Si(Q.sub.1)(Q.sub.2)(Q.sub.3), N(Q.sub.1)(Q.sub.2), B(Q.sub.1)(Q.sub.2), C(O)(Q.sub.1), S(O).sub.2(Q.sub.1), or P(O)(Q.sub.1)(Q.sub.2), [0188] R.sub.10a may be: [0189] deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, or a nitro group; [0190] a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 arylalkyl group, a C.sub.2-C.sub.60 heteroarylalkyl group, Si(Q.sub.11)(Q.sub.12)(Q.sub.13), N(Q.sub.11)(Q.sub.12), B(Q.sub.11)(Q.sub.12), C(O)(Q.sub.11), S(O).sub.2(Q.sub.11), P(O)(Q.sub.11)(Q.sub.12), or any combination thereof; [0191] a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 arylalkyl group, or a C.sub.2-C.sub.60 heteroarylalkyl group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 arylalkyl group, a C.sub.2-C.sub.60 heteroarylalkyl group, Si(Q.sub.21)(Q.sub.22)(Q.sub.23), N(Q.sub.21)(Q.sub.22), B(Q.sub.21)(Q.sub.22), C(O)(Q.sub.21), S(O).sub.2(Q.sub.21), P(O)(Q.sub.21)(Q.sub.22), or any combination thereof; or [0192] Si(Q.sub.31)(Q.sub.32)(Q.sub.33), N(Q.sub.31)(Q.sub.32), B(Q.sub.31)(Q.sub.32), C(O)(Q.sub.31), S(O).sub.2(Q.sub.31), or P(O)(Q.sub.31)(Q.sub.32), and [0193] Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 may each independently be: hydrogen; deuterium; F; Cl; Br; I; a hydroxyl group; a cyano group; a nitro group; or a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.
[0194] In an embodiment, the delayed fluorescence material may be one of Compounds DFD1 to DFD29, but the disclosure is not limited thereto.
##STR00095## ##STR00096## ##STR00097## ##STR00098## ##STR00099## ##STR00100## ##STR00101##
[0195] In an embodiment, the emission layer may emit fluorescent or phosphorescent blue light. The blue light may have a maximum emission wavelength in a range of about 380 nm to about 495 nm. For example, the blue light may have a maximum emission wavelength in a range of about 400 nm to about 490 nm. In an embodiment, the blue light may have a maximum emission wavelength in a range of about 420 nm to about 485 nm. In an embodiment, the blue light may have a maximum emission wavelength in a range of about 425 nm to about 480 nm. For example, the blue light may have a maximum emission wavelength in a range of about 430 nm to about 475 nm or in a range of about 440 nm to about 475 nm.
[0196] The expression (interlayer) includes an organometallic compound may mean that the (interlayer) may include one type of organometallic compound represented by Formula 1 or two or more different types of organometallic compounds, each independently represented by Formula 1.
[0197] In an embodiment, the interlayer may include only Compound 1 as the organometallic compound. For example, Compound 1 may be included in the emission layer of the light-emitting device. In another embodiment, the interlayer may include both Compound 1 and Compound 2 as organometallic compounds. For example, Compound 1 and Compound 2 may be included in a same layer (for example, both Compound 1 and Compound 2 may be included in the emission layer), or may be included in different layers (for example, Compound 1 may be included in the emission layer and Compound 2 may be included in the electron transport region).
[0198] In the specification, the term interlayer may refer to a single layer and/or multiple layers between the first electrode and the second electrode of the light-emitting device.
[0199] According to embodiments, an electronic apparatus may include the light-emitting device. The electronic apparatus may further include a thin-film transistor. For example, the electronic apparatus may further include a thin-film transistor including a source electrode and a drain electrode, wherein the first electrode of the light-emitting device may be electrically connected to the source electrode or the drain electrode. In an embodiment, the electronic apparatus may further include a color filter, a color conversion layer, a touch screen layer, a polarizing layer, or any combination thereof. Further details of the electronic apparatus may be found in the descriptions provided in the specification.
[0200] According to embodiments, an electronic equipment may include the light-emitting device as described above. In an embodiment, the electronic equipment may be, for example, a flat panel display, a curved display, a computer monitor, a medical monitor, a television, an advertisement board, an indoor light, an outdoor light, a signal light, a head-up display, a fully transparent display, a partially transparent display, a flexible display, a rollable display, a foldable display, a stretchable display, a laser printer, a telephone, a mobile phone, a tablet computer, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a microdisplay, a three-dimensional (3D) display, a virtual reality display, an augmented reality display, a vehicle, a video wall with multiple displays tiled together, a theater screen, a stadium screen, a phototherapy device, or a signboard. Further details of the electronic equipment may be found in the descriptions provided herein.
[Description of FIG. 1]
[0201]
[0202] Hereinafter, a structure of the light-emitting device 10 and a method of manufacturing the light-emitting device 10 are described with reference to
[First Electrode 110]
[0203] In
[0204] The first electrode 110 may be formed by, for example, depositing or sputtering a material for forming the first electrode 110 on the substrate. In cases where the first electrode 110 functions as an anode, a material for forming the first electrode 110 may be a high-work function material that facilitates hole injection.
[0205] The first electrode 110 may be a reflective electrode, a transflective electrode, or a transmissive electrode. In cases where the first electrode 110 is a transmissive electrode, a material for forming the first electrode 110 may include indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO.sub.2), zinc oxide (ZnO), or any combination thereof. In an embodiment, in cases where the first electrode 110 is a transflective electrode or a reflective electrode, a material for forming the first electrode 110 may include magnesium (Mg), silver (Ag), aluminum (Al), aluminum-lithium (AlLi), calcium (Ca), magnesium-indium (MgIn), magnesium-silver (MgAg), or any combination thereof.
[0206] The first electrode 110 may have a structure consisting of a single layer or a structure including multiple layers. In an embodiment, the first electrode 110 may have a three-layer structure of ITO/Ag/ITO.
[Interlayer 130]
[0207] The interlayer 130 may be arranged on the first electrode 110. The interlayer 130 may include the emission layer.
[0208] The interlayer 130 may further include a hole transport region between the first electrode 110 and the emission layer, and an electron transport region between the emission layer and the second electrode 150.
[0209] In addition to various organic materials, the interlayer 130 may further include a metal-containing compound such as an organometallic compound, an inorganic material such as quantum dots, or the like.
[0210] In an embodiment, the interlayer 130 may include two or more emitting units sequentially stacked between the first electrode 110 and the second electrode 150, and at least one charge generation layer, each between adjacent units among the or more two emitting units. In cases where the interlayer 130 includes the two or more emitting units and that at least one charge generation layer as described above, the light-emitting device 10 may be a tandem light-emitting device.
[Hole Transport Region in Interlayer 130]
[0211] The hole transport region may have a structure consisting of a layer consisting of a single material, a structure consisting of a layer including different materials, or a structure including multiple layers including different materials.
[0212] The hole transport region may include a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof.
[0213] In an embodiment, the hole transport region may have a multilayer structure, such as a hole injection layer/hole transport layer structure, a hole injection layer/hole transport layer/emission auxiliary layer structure, a hole injection layer/emission auxiliary layer structure, a hole transport layer/emission auxiliary layer structure, or a hole injection layer/hole transport layer/electron blocking layer structure, wherein the layers of each structure may stacked from the first electrode 110 in its respective stated order, but the structure of the hole transport region is not limited thereto.
[0214] In an embodiment, the hole transport region may include a compound represented by Formula 201, a compound represented by Formula 202, or any combination thereof:
##STR00102##
[0215] In Formulae 201 and 202, [0216] L.sub.201 to L.sub.204 may each independently be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0217] L.sub.205 may be *O*, *S*, *N(Q.sub.201)-*, a C.sub.1-C.sub.20 alkylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.20 alkenylene group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0218] xa1 to xa4 may each independently be an integer from 0 to 5, [0219] xa5 may be an integer from 1 to 10, [0220] R.sub.201 to R.sub.204 and Q.sub.201 may each independently be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0221] R.sub.201 and R.sub.202 may optionally be linked to each other via a single bond, a C.sub.1-C.sub.5 alkylene group that is unsubstituted or substituted with at least one R.sub.10a, or a C.sub.2-C.sub.5 alkenylene group that is unsubstituted or substituted with at least one R.sub.10a to form a C.sub.8-C.sub.60 polycyclic group (for example, a carbazole group) that is unsubstituted or substituted with at least one R.sub.10a (for example, Compound HT16), [0222] R.sub.203 and R.sub.204 may optionally be linked to each other via a single bond, a C.sub.1-C.sub.5 alkylene group that is unsubstituted or substituted with at least one R.sub.10a, or a C.sub.2-C.sub.5 alkenylene group that is unsubstituted or substituted with at least one R.sub.10a to form a C.sub.8-C.sub.60 polycyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0223] R.sub.10a may be the same as described herein, and [0224] na1 may be an integer from 1 to 4.
[0225] In an embodiment, the compound represented by Formulae 201 and the compound represented by Formula 202 may each independently include at least one of groups represented by Formulae CY201 to CY217:
##STR00103## ##STR00104## ##STR00105## ##STR00106## ##STR00107## ##STR00108## ##STR00109## ##STR00110##
[0226] In Formulae CY201 to CY217, R.sub.10b and R.sub.10c may each independently be as described in connection with R.sub.10a, ring CY.sub.201 to ring CY.sub.204 may each independently be a C.sub.3-C.sub.20 carbocyclic group or a C.sub.1-C.sub.20 heterocyclic group, and at least one hydrogen in Formulae CY201 to CY217 may be unsubstituted or substituted with R.sub.10a as described herein.
[0227] In an embodiment, ring CY.sub.201 to ring CY.sub.204 in Formulae CY201 to CY217 may each independently be a benzene group, a naphthalene group, a phenanthrene group, or an anthracene group.
[0228] In an embodiment, the compound represented by Formulae 201 and the compound represented by Formula 202 may each include at least one of groups represented by Formulae CY201 to CY203.
[0229] In an embodiment, the compound represented by Formula 201 may include at least one of groups represented by Formulae CY201 to CY203 and at least one of groups represented by Formulae CY204 to CY217.
[0230] In an embodiment, in Formula 201, xa1 may be 1, R.sub.201 may be a group represented by one of Formulae CY201 to CY203, xa2 may be 0, and R.sub.202 may be a group represented by one of Formulae CY204 to CY207.
[0231] In an embodiment, the compound represented by Formulae 201 and the compound represented by Formula 202 may each exclude groups represented by Formulae CY201 to CY203.
[0232] In an embodiment, the compound represented by Formulae 201 and the compound represented by Formula 202 may each exclude groups represented by Formulae CY201 to CY203 and may each independently include at least one of groups represented by Formulae CY204 to CY217.
[0233] In an embodiment, the compound represented by Formulae 201 and the compound represented by Formula 202 may each exclude groups represented by Formulae CY201 to CY217.
[0234] For example, the hole transport region may include one of Compounds HT1 to HT46, m-MTDATA, TDATA, 2-TNATA, NPB (NPD), -NPB, TPD, spiro-TPD, spiro-NPB, methylated NPB, TAPC, HMTPD, 4,4,4-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline/dodecylbenzenesulfonic acid (PANI/DBSA), poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PEDOT/PSS), polyaniline/camphor sulfonic acid (PANI/CSA), polyaniline/poly(4-styrenesulfonate) (PANI/PSS), or any combination thereof:
##STR00111## ##STR00112## ##STR00113## ##STR00114## ##STR00115##
[0235] A thickness of the hole transport region may be in a range of about 50 to about 10,000 . For example, the thickness of the hole transport region may be in a range of about 100 to about 4,000 . In cases where the hole transport region includes a hole injection layer, a hole transport layer, or any combination thereof, a thickness of the hole injection layer may each independently be in a range of about 100 to about 9,000 , and a thickness of the hole transport layer may be in a range of about 50 to about 2,000 . For example, the thickness of the hole injection layer may be in a range of about 100 to about 1,000 . For example, the thickness of the hole transport layer may be in a range of about 100 to about 1,500 . In cases where the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within the ranges described above, satisfactory hole transporting characteristics may be obtained without a substantial increase in driving voltage.
[0236] The emission auxiliary layer may increase light-emission efficiency by compensating for an optical resonance distance according to a wavelength of light emitted by the emission layer, and the electron blocking layer may block the leakage of electrons from the emission layer to the hole transport region. Materials that may be included in the hole transport region may be included in the emission auxiliary layer and the electron blocking layer.
[p-Dopant]
[0237] The hole transport region may further include, in addition to these materials, a charge-generation material to improve conductive properties. The charge-generation material may be uniformly or non-uniformly dispersed in the hole transport region (for example, as a single layer consisting of a charge-generation material).
[0238] The charge-generation material may be, for example, a p-dopant.
[0239] For example, the lowest unoccupied molecular orbital (LUMO) energy of the p-dopant may be less than or equal to about 3.5 eV.
[0240] In an embodiment, the p-dopant may include a quinone derivative, a cyano group-containing compound, a compound including element EL1 and element EL2, or any combination thereof.
[0241] Examples of quinone derivatives may include TCNQ and F4-TCNQ.
[0242] Examples of cyano group-containing compounds may include HAT-CN and a compound represented by Formula 221.
##STR00116##
[0243] In Formula 221, [0244] R.sub.221 to R.sub.223 may each independently be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, and [0245] at least one of R.sub.221 to R.sub.223 may each independently be a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, each substituted with: a cyano group; F; Cl; Br; I; a C.sub.1-C.sub.20 alkyl group substituted with a cyano group, F, Cl, Br, I, or any combination thereof; or any combination thereof.
[0246] In the compound including element EL1 and element EL2, element EL1 may be a metal, a metalloid, or a combination thereof, and element EL2 may be a non-metal, a metalloid, or a combination thereof.
[0247] Examples of a metal may include: an alkali metal (for example, lithium (Li), sodium (Na), potassium (K), rubidium (Rb), cesium (Cs), etc.); an alkaline earth metal (for example, beryllium (Be), magnesium (Mg), calcium (Ca), strontium (Sr), barium (Ba), etc.); a transition metal (for example, titanium (Ti), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), manganese (Mn), technetium (Tc), rhenium (Re), iron (Fe), ruthenium (Ru), osmium (Os), cobalt (Co), rhodium (Rh), iridium (Ir), nickel (Ni), palladium (Pd), platinum (Pt), copper (Cu), silver (Ag), gold (Au), etc.); a post-transition metal (for example, zinc (Zn), indium (In), tin (Sn), etc.); and a lanthanide metal (for example, lanthanum (La), cerium (Ce), praseodymium (Pr), neodymium (Nd), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), lutetium (Lu), etc.).
[0248] Examples of a metalloid may include silicon (Si), antimony (Sb), and tellurium (Te).
[0249] Examples of a non-metal may include oxygen (O) and a halogen (for example, F, Cl, Br, I, etc.).
[0250] Examples of a compound including element EL1 and element EL2 may include a metal oxide, a metal halide (for example, a metal fluoride, a metal chloride, a metal bromide, a metal iodide, etc.), a metalloid halide (for example, a metalloid fluoride, a metalloid chloride, a metalloid bromide, a metalloid iodide, etc.), a metal telluride, or any combination thereof.
[0251] Examples of a metal oxide may include a tungsten oxide (for example, WO, W.sub.2O.sub.3, WO.sub.2, WO.sub.3, W.sub.2O.sub.5, etc.), a vanadium oxide (for example, VO, V.sub.2O.sub.3, VO.sub.2, V.sub.2O.sub.5, etc.), a molybdenum oxide (MoO, Mo.sub.2O.sub.3, MoO.sub.2, MoO.sub.3, Mo.sub.2O.sub.5, etc.), and a rhenium oxide (for example, ReO.sub.3, etc.).
[0252] Examples of a metal halide may include an alkali metal halide, an alkaline earth metal halide, a transition metal halide, a post-transition metal halide, and a lanthanide metal halide.
[0253] Examples of an alkali metal halide may include LiF, NaF, KF, RbF, CsF, LiCl, NaCl, KCl, RbCl, CsCl, LiBr, NaBr, KBr, RbBr, CsBr, LiI, NaI, Kl, RbI, and CsI.
[0254] Examples of an alkaline earth metal halide may include BeF.sub.2, MgF.sub.2, CaF.sub.2, SrF.sub.2, BaF.sub.2, BeCl.sub.2, MgCl.sub.2, CaCl.sub.2), SrCl.sub.2, BaCl.sub.2, BeBr.sub.2, MgBr.sub.2, CaBr.sub.2, SrBr.sub.2, BaBr.sub.2, BeI.sub.2, MgI.sub.2, CaI.sub.2, SrI.sub.2, and BaI.sub.2.
[0255] Examples of a transition metal halide may include a titanium halide (for example, TiF.sub.4, TiCl.sub.4, TiBr.sub.4, TiI.sub.4, etc.), a zirconium halide (for example, ZrF.sub.4, ZrCl.sub.4, ZrBr.sub.4, ZrI.sub.4, etc.), a hafnium halide (for example, HfF.sub.4, HfCl.sub.4, HfBr.sub.4, HfI.sub.4, etc.), a vanadium halide (for example, VF.sub.3, VCl.sub.3, VBrs, VI.sub.3, etc.), a niobium halide (for example, NbF.sub.3, NbCIs, NbBrs, NbI.sub.3, etc.), a tantalum halide (for example, TaF.sub.3, TaCl.sub.3, TaBr.sub.3, TaI.sub.3, etc.), a chromium halide (for example, CrF.sub.3, CrCl.sub.3, CrBr.sub.3, CrI.sub.3, etc.), a molybdenum halide (for example, MoF.sub.3, MoCl.sub.3, MoBr.sub.3, MoI.sub.3, etc.), a tungsten halide (for example, WF.sub.3, WCl.sub.3, WBr.sub.3, WI.sub.3, etc.), a manganese halide (for example, MnF.sub.2, MnCl.sub.2, MnBr.sub.2, MnI.sub.2, etc.), a technetium halide (for example, TcF.sub.2, TcCl.sub.2, TcBr.sub.2, TcI.sub.2, etc.), a rhenium halide (for example, ReF.sub.2, ReCl.sub.2, ReBr.sub.2, ReI.sub.2, etc.), an iron halide (for example, FeF.sub.2, FeCl.sub.2, FeBr.sub.2, FeI.sub.2, etc.), a ruthenium halide (for example, RuF.sub.2, RuCl.sub.2, RuBr.sub.2, RuI.sub.2, etc.), an osmium halide (for example, OsF.sub.2, OsCl.sub.2, OsBr.sub.2, OsI.sub.2, etc.), a cobalt halide (for example, CoF.sub.2, COCl.sub.2, CoBr.sub.2, CoI.sub.2, etc.), a rhodium halide (for example, RhF.sub.2, RhCl.sub.2, RhBr.sub.2, RhI.sub.2, etc.), an iridium halide (for example, IrF.sub.2, IrCl.sub.2, IrBr.sub.2, IrI.sub.2, etc.), a nickel halide (for example, NiF.sub.2, NiCl.sub.2, NiBr.sub.2, NiI.sub.2, etc.), a palladium halide (for example, PdF.sub.2, PdCl.sub.2, PdBr.sub.2, PdI.sub.2, etc.), a platinum halide (for example, PtF.sub.2, PtCl.sub.2, PtBr.sub.2, PtI.sub.2, etc.), a copper halide (for example, CuF, CuCl, CuBr, CuI, etc.), a silver halide (for example, AgF, AgCl, AgBr, AgI, etc.), and a gold halide (for example, AuF, AuCl, AuBr, AuI, etc.).
[0256] Examples of a post-transition metal halide may include a zinc halide (for example, ZnF.sub.2, ZnCl.sub.2, ZnBr.sub.2, ZnI.sub.2, etc.), an indium halide (for example, Ink.sub.3d, etc.), and a tin halide (for example, SnI.sub.2, etc.).
[0257] Examples of a lanthanide metal halide may include YbF, YbF.sub.2, YbF.sub.3, SmF.sub.3, YbCl, YbCl.sub.2, YbCl.sub.3 SmCl.sub.3, YbBr, YbBr.sub.2, YbBr.sub.3, SmBr.sub.3, YbI, YbI.sub.2, YbI.sub.3, and SmI.sub.3.
[0258] Examples of the metalloid halide may include an antimony halide (for example, SbCl.sub.5, etc.).
[0259] Examples of a metal telluride may include an alkali metal telluride (for example, Li.sub.2Te, Na.sub.2Te, K.sub.2Te, Rb.sub.2Te, Cs.sub.2Te, etc.), an alkaline earth metal telluride (for example, BeTe, MgTe, CaTe, SrTe, BaTe, etc.), a transition metal telluride (for example, TiTe.sub.2, ZrTe.sub.2, HfTe.sub.2, V.sub.2Te.sub.3, Nb.sub.2Te.sub.3, Ta.sub.2Te.sub.3, Cr.sub.2Te.sub.3, Mo.sub.2Te.sub.3, W.sub.2Te.sub.3, MnTe, TcTe, ReTe, FeTe, RuTe, OsTe, CoTe, RhTe, IrTe, NiTe, PdTe, PtTe, Cu.sub.2Te, CuTe, Ag.sub.2Te, AgTe, Au.sub.2Te, etc.), a post-transition metal telluride (for example, ZnTe, etc.), and a lanthanide metal telluride (for example, LaTe, CeTe, PrTe, NdTe, PmTe, EuTe, GdTe, TbTe, DyTe, HoTe, ErTe, TmTe, YbTe, LuTe, etc.).
[Emission Layer in Interlayer 130]
[0260] In cases where the light-emitting device 10 is a full-color light-emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, and/or a blue emission layer, according to a subpixel. In an embodiment, the emission layer may have a stacked structure of two or more layers of a red emission layer, a green emission layer, and a blue emission layer, in which the two or more layers may contact each other or be separated from each other, to emit white light. In embodiments, the emission layer may include two or more materials of a red light-emitting material, a green light-emitting material, and a blue light-emitting material, in which the two or more materials are mixed with each other in a single layer, to emit white light. For example, the emission layer may emit blue light.
[0261] In an embodiment, the emission layer may include the organometallic compound represented by Formula 1 as described herein.
[0262] The emission layer may include a host and a dopant.
[0263] In an embodiment, the dopant may include the organometallic compound represented by Formula 1 as described herein. The dopant may further include a phosphorescent dopant, a fluorescent dopant, a delayed fluorescence material, or any combination thereof, in addition to the organometallic compound represented by Formula 1. In addition to the organometallic compound represented by Formula 1, the phosphorescent dopant, the fluorescent dopant, and the like that may be further included in the emission layer are each as described below.
[0264] An amount of the dopant in the emission layer may be in a range of about 0.01 wt % to about 20 wt %, based on 100 wt % of the host. For example, the amount of the dopant in the emission layer may be in a range of about 0.01 wt % to about 15 wt %.
[0265] In an embodiment, the emission layer may include quantum dots.
[0266] In an embodiment, the emission layer may include a delayed fluorescence material. The delayed fluorescence material may serve as either a host or as a dopant in the emission layer.
[0267] A thickness of the emission layer may be in a range of about 100 to about 1,000 . For example, the thickness of the emission layer may be in a range of about 200 to about 600 . In cases where the thickness of the emission layer is within any of these ranges, excellent light-emission characteristics may be obtained without a substantial increase in driving voltage.
[Host]
[0268] The host may include, for example, a carbazole-containing compound, an anthracene-containing compound, or any combination thereof.
[0269] In an embodiment, the host may include a compound represented by Formula 301:
##STR00117##
[0270] In Formula 301, [0271] Ar.sub.301 and L.sub.301 may each independently be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0272] R.sub.10a may be the same as described in Formula 1, [0273] xb11 may be 1, 2, or 3, [0274] xb1 may be an integer from 0 to 5, [0275] R.sub.301 may be hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkenyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.2-C.sub.60 alkynyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 alkoxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, Si(Q.sub.301)(Q.sub.302)(Q.sub.303), N(Q.sub.301)(Q.sub.302), B(Q.sub.301)(Q.sub.302), C(O)(Q.sub.301), S(O).sub.2(Q.sub.301), or P(O)(Q.sub.301)(Q.sub.302), [0276] xb21 may be an integer of 1 to 5, and [0277] Q.sub.301 to 0303 may each independently be the same as described in connection with Q.sub.1.
[0278] In an embodiment, in Formula 301, when xb11 is 2 or more, two or more of Ar.sub.301 may be linked to each other via a single bond.
[0279] In an embodiment, the host may include a compound represented by Formula 301-1, a compound represented by Formula 301-2, or any combination thereof:
##STR00118##
[0280] In Formulae 301-1 and 301-2, [0281] ring A.sub.301 to ring A.sub.304 may each independently be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0282] X.sub.301 may be O, S, N-[(L.sub.304).sub.xb4-R.sub.304], C(R.sub.304)(R.sub.305), or Si(R.sub.304)(R.sub.305), [0283] xb22 and xb23 may each independently be 0, 1, or 2, [0284] L.sub.301, xb1, and R.sub.301 may each be the same as described herein, [0285] L.sub.302 to L.sub.304 may each independently be the same as described in connection with L.sub.301, [0286] xb2 to xb4 may each independently be the same as described in connection with xb1, and [0287] R.sub.302 to R.sub.305 and R.sub.311 to R.sub.314 may each be the same as described in connection with R.sub.301.
[0288] In an embodiment, the host may include an alkali earth metal complex, a post-transition metal complex, or any combination thereof. In an embodiment, the host may include a Be complex (for example, Compound H55), an Mg complex, a Zn complex, or any combination thereof.
[0289] In an embodiment, the host may include one of Compounds H1 to H128, 9,10-di(2-naphthyl)anthracene (ADN), 2-methyl-9,10-bis(naphthalen-2-yl)anthracene (MADN), 9,10-di-(2-naphthyl)-2-t-butyl-anthracene (TBADN), 4,4-bis(N-carbazolyl)-1,1-biphenyl (CBP), 1,3-di-(9-carbazolyl)benzene (mCP), 1,3,5-tri(carbazol-9-yl)benzene (TCP), or any combination thereof:
##STR00119## ##STR00120## ##STR00121## ##STR00122## ##STR00123## ##STR00124## ##STR00125## ##STR00126## ##STR00127## ##STR00128## ##STR00129## ##STR00130## ##STR00131## ##STR00132## ##STR00133## ##STR00134## ##STR00135## ##STR00136## ##STR00137## ##STR00138## ##STR00139## ##STR00140## ##STR00141## ##STR00142## ##STR00143## ##STR00144## ##STR00145## ##STR00146##
##STR00147## ##STR00148## ##STR00149## ##STR00150## ##STR00151## ##STR00152##
[0290] In an embodiment, the host may include a first host compound and a second host compound.
[0291] In an embodiment, the first host compound may be a hole-transporting host.
[0292] In an embodiment, the second host compound may be an electron-transporting host.
[0293] In an embodiment, the term hole-transporting host may refer to a compound that includes a hole-transporting moiety.
[0294] In an embodiment, the term electron-transporting host may refer not only to a compound that includes an electron-transporting moiety but also to a compound having bipolar properties.
[0295] As used herein, the terms hole-transporting host and electron-transporting host may each be understood according to a relative difference between hole mobility and electron mobility in the hole-transporting host and the electron-transporting host. For example, even when the electron-transporting host does not include an electron-transporting moiety, a bipolar compound exhibiting relatively higher electron mobility than the hole-transporting host may still be considered as the electron-transporting host.
[0296] In an embodiment, the hole-transporting host may be represented by any one of Formulae 311-1 to 311-6, and the electron-transporting host may be represented by any one of Formulae 312-1 to 312-4 and 313:
##STR00153## ##STR00154##
[0297] Formulae 311-1 to 311-6, 312-1 to 312-4, 313, and 313A are each the same as described in the specification.
[0298] In an embodiment, the first host compound and the second host compound may form an exciplex.
[Phosphorescent Dopant]
[0299] The phosphorescent dopant may include at least one transition metal as a central metal.
[0300] The phosphorescent dopant may include a monodentate ligand, a bidentate ligand, a tridentate ligand, a tetradentate ligand, a pentadentate ligand, a hexadentate ligand, or any combination thereof.
[0301] The phosphorescent dopant may be electrically neutral.
[0302] In an embodiment, the phosphorescent dopant may include the organometallic compound represented by Formula 1.
[0303] In an embodiment, the phosphorescent dopant may include an organometallic compound represented by Formula 401:
##STR00155##
[0304] In Formulae 401 and 402, [0305] M may be a transition metal (for example, iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (Ti), gold (Au), hafnium (Hf), europium (Eu), terbium (Tb), rhodium (Rh), rhenium (Re), or thulium (Tm)), [0306] L.sub.401 may be a ligand represented by Formula 402, and xc1 may be 1, 2, or 3, wherein when xc1 is 2 or more, two or more of L.sub.401 may be identical to or different from each other, [0307] L.sub.402 may be an organic ligand, and xc2 may be 0, 1, 2, 3, or 4, wherein when xc2 is 2 or more, two or more of L.sub.402 may be identical to or different from each other, [0308] X.sub.401 and X.sub.402 may each independently be nitrogen or carbon, [0309] ring A.sub.401 and ring A.sub.402 may each independently be a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group, [0310] T.sub.401 may be a single bond, *O*, *S, *C(O)*, *N(Q.sub.411)*, *C(Q.sub.411)(Q.sub.412)-*, *C(Q.sub.411)C(Q.sub.412)-*, *C(Q.sub.411)=*, or *C*, [0311] X.sub.403 and X.sub.404 may each independently be a chemical bond (for example, a covalent bond or a coordinate bond), O, S, N(Q.sub.413), B(Q.sub.413), P(Q.sub.413), C(Q.sub.413)(Q.sub.414), or Si(Q.sub.413)(Q.sub.414), [0312] Q.sub.411 to Q.sub.414 may each independently be the same as described in connection with Q.sub.1, [0313] R.sub.401 and R.sub.402 may each independently be hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.20 alkoxy group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, Si(Q.sub.401)(Q.sub.402)(Q.sub.403), N(Q.sub.401)(Q.sub.402), B(Q.sub.401)(Q.sub.402), C(O)(Q.sub.401), S(O).sub.2(Q.sub.401), or P(O)(Q.sub.401)(Q.sub.402), [0314] Q.sub.401 to Q.sub.403 may each independently be the same as described in connection with Q.sub.1, [0315] xc11 and xc12 may each independently be an integer from 0 to 10, and [0316] * and * in Formula 402 each indicate a binding site to M in Formula 401.
[0317] For example, in Formula 402, X.sub.401 may be nitrogen and X.sub.402 may be carbon, or X.sub.401 and X.sub.402 may each be nitrogen.
[0318] In an embodiment, in Formula 401, when xc1 is 2 or more, two rings A.sub.401 among two or more of L.sub.401 may be optionally linked together via T.sub.402, which is a linking group, and two rings A.sub.402 may be optionally linked together via T.sub.403, which is another linking group (see Compounds PD1 to PD4 and PD7). T.sub.402 and T.sub.403 may each independently be the same as described in connection with T.sub.401.
[0319] In Formula 401, L.sub.402 may be an organic ligand. For example, L.sub.402 may include a halogen group, a diketone group (for example, an acetylacetonate group), a carboxylic acid group (for example, a picolinate group), C(O) group, an isonitrile group, a CN group, a phosphorus group (for example, a phosphine group, a phosphite group, etc.), or any combination thereof.
[0320] The phosphorescent dopant may include, for example, one of Compounds PD1 to PD39, or any combination thereof:
##STR00156## ##STR00157## ##STR00158## ##STR00159## ##STR00160## ##STR00161## ##STR00162## ##STR00163## ##STR00164## ##STR00165##
[Fluorescent Dopant]
[0321] The fluorescent dopant may include an amine group-containing compound, a styryl group-containing compound, or any combination thereof.
[0322] In an embodiment, the fluorescent dopant may include a compound represented by Formula 501:
##STR00166##
[0323] In Formula 501, [0324] Ar.sub.501, L.sub.501 to L.sub.503, R.sub.501, and R.sub.502 may each independently be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0325] R.sub.10a may be the same as described in Formula 1, [0326] xd1 to xd3 may each independently be 0, 1, 2, or 3, and [0327] xd4 may be 1, 2, 3, 4, 5, or 6.
[0328] In an embodiment, in Formula 501, Ar.sub.501 may be a condensed cyclic group (for example, an anthracene group, a chrysene group, a pyrene group, etc.) in which three or more monocyclic groups are condensed together.
[0329] In an embodiment, in Formula 501, xd4 may be 2.
[0330] In an embodiment, the fluorescent dopant may include: at least one of Compounds FD1 to FD37, DPVBi, and DPAVBi:
##STR00167## ##STR00168## ##STR00169## ##STR00170## ##STR00171##
[Delayed Fluorescence Material]
[0331] The emission layer may further include a delayed fluorescence material.
[0332] In embodiments, the delayed fluorescence material may be selected from compounds capable of emitting delayed fluorescence based on a delayed fluorescence emission mechanism.
[0333] The delayed fluorescence material included in the emission layer may serve as a host or a dopant, depending on the types of other materials included in the emission layer.
[0334] In an embodiment, a difference between a triplet energy level (eV) of the delayed fluorescence material and a singlet energy level (eV) of the delayed fluorescence material may be in a range of about 0 eV to about 0.5 eV. In cases where a difference between the triplet energy level (eV) of the delayed fluorescence material and the singlet energy level (eV) of the delayed fluorescence material falls within this range, up-conversion from the triplet state to the singlet state of the delayed fluorescence materials may effectively occur, thereby enhancing the luminescence efficiency of the light-emitting device 10.
[0335] In an embodiment, the delayed fluorescence material may include a material including at least one electron donor (for example, a electron-rich C.sub.3-C.sub.60 cyclic group such as a carbazole group) and at least one electron acceptor (for example, a sulfoxide group, a cyano group, a electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group, and the like), or a material including a C.sub.8-C.sub.60 polycyclic group including at least two cyclic groups that are condensed together while sharing boron (B).
[0336] In an embodiment, the delayed fluorescence material may include, but is not limited to, at least one of Compounds DF1 to DF9:
[0337] In an embodiment, the delayed fluorescence material may be represented by Formula 701 or Formula 702:
##STR00172##
[0338] Formulae 701 and 702 are each the same as described in the specification.
[0339] Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 may each independently be: hydrogen; deuterium; F; Cl; Br; I; a hydroxyl group; a cyano group; a nitro group; or a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, or a C.sub.1-C.sub.60 heterocyclic group, each unsubstituted or substituted with deuterium, F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.
[0340] In an embodiment, the delayed fluorescence material may include, but is not limited to, at least one of Compounds DF1 to DF14 and DFD1 to DFD29:
##STR00173## ##STR00174## ##STR00175## ##STR00176## ##STR00177## ##STR00178## ##STR00179## ##STR00180## ##STR00181## ##STR00182## ##STR00183## ##STR00184## ##STR00185##
[Quantum Dot]
[0341] The emission layer may include quantum dots.
[0342] As used herein, the term quantum dot refers to a crystal of a semiconductor compound. Quantum dots may emit light of various wavelengths depending on a size of the crystal. Quantum dots may emit light of various wavelengths by adjusting a ratio of elements in a quantum dot compound.
[0343] A diameter of a quantum dot may be, for example, in a range of about 1 nm to about 10 nm.
[0344] Quantum dots may be synthesized by a wet chemical process, a metal organic chemical vapor deposition (MOCVD) process, a molecular beam epitaxy (MBE) process, or any process similar thereto.
[0345] The wet chemical process may involve mixing a precursor material with an organic solvent and growing quantum dot crystals. As the crystal grows, the organic solvent acts as a surface-coordinating dispersant that controls the growth of the crystal. Therefore, the wet chemical process may be more readily performed than vapor deposition methods, such as metal organic chemical vapor deposition (MOCVD) or molecular beam epitaxy (MBE), and may allow for controlled growth of quantum dots via a low-cost process.
[0346] The quantum dot may include: a Group II-VI semiconductor compound; a Group III-V semiconductor compound; a Group III-VI semiconductor compound; a Group I-III-VI semiconductor compound; a Group IV-VI semiconductor compound; a Group IV element or compound; or any combination thereof.
[0347] Examples of a Group II-VI semiconductor compound may include: a binary compound, such as CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, ZnO, HgS, HgSe, HgTe, MgSe, or MgS; a ternary compound, such as CdSeS, CdSeTe, CdSTe, ZnSeS, ZnSeTe, ZnSTe, HgSeS, HgSeTe, HgSTe, CdZnS, CdZnSe, CdZnTe, CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe, HgZnTe, MgZnSe, or MgZnS; a quaternary compound, such as CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, HgZnSeTe, or HgZnSTe; and any combination thereof.
[0348] Examples of a Group III-V semiconductor compound may include: a binary compound, such as GaN, GaP, GaAs, GaSb, AlN, AIP, AIAs, AISb, InN, InP, InAs, or InSb; a ternary compound, such as GaNP, GaNAs, GaNSb, GaPAs, GaPSb, AlNP, AlNAs, AlNSb, AIPAs, AIPSb, InGaP, InNP, InAlP, InNAs, InNSb, InPAs, InPSb, or GaAINP; a quaternary compound, such as GaAINAs, GaAINSb, GaAIPAs, GaAIPSb, GaInNP, GaInNAs, GaInNSb, GaInPAs, GaInPSb, InAlNP, InAlNAs, InAlNSb, InAlPAs, or InAlPSb; and any combination thereof. In an embodiment, a Group III-V semiconductor compound may further include a Group II element. Examples of a Group III-V semiconductor compound further including a Group II element may include InZnP, InGaZnP, and InAlZnP.
[0349] Examples of a Group III-VI semiconductor compound may include: a binary compound, such as GaS, Ga.sub.2S.sub.3, GaSe, Ga.sub.2Se.sub.3, GaTe, InS, InSe, In.sub.2Se.sub.3, InTe, etc.; a ternary compound, such as InGaS.sub.3, InGaSe.sub.2, etc.; and any combination thereof.
[0350] Examples of a Group IIII-VI semiconductor compound may include: a ternary compound, such as AgInS, AgInS.sub.2, AgInSe.sub.2, AgGaS, AgGaS.sub.2, AgGaSe.sub.2, CuInS, CuInS.sub.2, CuInSe.sub.2, CuGaS.sub.2, CuGaSe.sub.2, CuGaO.sub.2, AgGaO.sub.2, AgAlO.sub.2, etc.; a quaternary compound, such as AgInGaS.sub.2, AgInGaSe.sub.2, etc.; and any combination thereof.
[0351] Examples of a Group IV-VI semiconductor compound may include: a binary compound, such as SnS, SnSe, SnTe, PbS, PbSe, or PbTe; a ternary compound, such as SnSeS, SnSeTe, SnSTe, PbSeS, PbSeTe, PbSTe, SnPbS, SnPbSe, or SnPbTe; a quaternary compound, such as SnPbSSe, SnPbSeTe, or SnPbSTe; or any combination thereof.
[0352] Examples of a Group IV element or compound may include: a single element material, such as Si or Ge; a binary compound, such as SiC or SiGe; and any combination thereof.
[0353] Each element included in a compound, such as a binary compound, a ternary compound, or a quaternary compound, may be present at a uniform or non-uniform concentration in a particle. The formulae above may refer to types of elements included in the compound, with varying element ratios. For example, AgInGaS.sub.2 may represent AgIn.sub.xGa.sub.1-xS.sub.2 (wherein x is a real number between 0 and 1).
[0354] In an embodiment, the quantum dot may have a single structure in which the concentration of each element in the quantum dot is uniform, or it may have a core-shell structure. In an embodiment, in cases where the quantum dot has a core-shell structure, a material included in the core and a material included in the shell may be different from each other.
[0355] The shell of the quantum dot may serve as a protective layer that prevents chemical denaturation of the core to maintain semiconductor characteristics, and/or may serve as a charging layer that imparts electrophoretic characteristics to the quantum dot. The shell may be a single layer or a multilayer structure. The interface between the core and the shell may have a concentration gradient in which the concentration of a material present in the shell decreases toward the center of the core.
[0356] Examples of the shell of the quantum dot may include a metal or non-metal oxide, a semiconductor compound, and any combination thereof. Examples of the metal or non-metal oxide may include: a binary compound, such as SiO.sub.2, Al.sub.2O.sub.3, TiO.sub.2, ZnO, MnO, Mn.sub.2O.sub.3, Mn.sub.3O.sub.4, CuO, FeO, Fe.sub.2O.sub.3, Fe.sub.3O.sub.4, CoO, Co.sub.3O.sub.4, NiO, etc.; a ternary compound, such as MgAl.sub.2O.sub.4, CoFe.sub.2O.sub.4, NiFe.sub.2O.sub.4, CoMn.sub.2O.sub.4, etc.; or any combination thereof. Examples of the semiconductor compound may include: a Group III-VI semiconductor compound; a Group II-VI semiconductor compound; a Group III-V semiconductor compound; a Group III-VI semiconductor compound; a Group I-III-VI semiconductor compound; a Group IV-VI semiconductor compound; or any combination thereof, as described herein. For example, the semiconductor compound may include CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, ZnSeS, ZnTeS, GaAs, GaP, GaS, GaSe, AgGaS, AgGaS.sub.2, GaSb, HgS, HgSe, HgTe, InAs, InP, InGaP, InSb, AlAs, AIP, AlSb, or any combination thereof.
[0357] Each element in a compound with multiple elements, such as a binary compound and a ternary compound, may be present at a uniform or non-uniform concentration in a particle. The formulae above may refer to types of elements included in the compound, where the element ratios in the compound may vary.
[0358] The quantum dot may have a full width at half maximum (FWHM) of an emission wavelength spectrum less than or equal to about 45 nm. For example, the quantum dot may have an FWHM of an emission wavelength spectrum less than or equal to about 40 nm. For example, the quantum dot may have an FWHM of an emission wavelength spectrum less than or equal to about 30 nm. In cases where the FWHM of the quantum dot is within any of these ranges, the quantum dot may have improved color purity or improved color reproducibility. Since light emitted through the quantum dot is radiated in all directions, a wide viewing angle may be achieved.
[0359] In an embodiment, the quantum dot may be in the form of spherical nanoparticles, pyramidal nanoparticles, multi-arm nanoparticles, cubic nanoparticles, nanotubes, nanowires, nanofibers, or nanoplates.
[0360] Since an energy band gap may be controlled by adjusting the size of the quantum dots or the ratio of elements in the quantum dot compound, light of various wavelengths may be obtained from the quantum dot-containing emission layer.
[0361] Therefore, by using the aforementioned quantum dots (either by varying quantum dot sizes or element ratios in the quantum dot compound), a light-emitting device capable of emitting light of various wavelengths may be implemented. In an embodiment, the size of the quantum dots or the element ratio in the quantum dot compound may be selected to emit red light, green light, and/or blue light. In an embodiment, the size of the quantum dots may emit white light through the combination of various colors.
[Electron Transport Region in Interlayer 130]
[0362] The electron transport region may have a structure consisting of a layer consisting of a single material, a structure consisting of a layer including different materials, or a structure including multiple layers including different materials.
[0363] The electron transport region may include a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, an electron injection layer, or any combination thereof.
[0364] In an embodiment, the electron transport region may have an electron transport layer/electron injection layer structure, a hole blocking layer/electron transport layer/electron injection layer structure, an electron control layer/electron transport layer/electron injection layer structure, or a buffer layer/electron transport layer/electron injection layer structure, wherein the layers of each structure may be stacked from the emission layer in its respective stated order, but the structure of the electron transport region is not limited thereto.
[0365] The electron transport region (for example, a buffer layer, a hole blocking layer, an electron control layer, or an electron transport layer in the electron transport region) may include a metal-free compound including at least one electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group.
[0366] In an embodiment, the electron transport region may include a compound represented by Formula 601.
##STR00186##
[0367] In Formula 601, [0368] Ar.sub.601 and L.sub.601 may each independently be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, [0369] xe11 may be 1, 2, or 3, [0370] xe1 may be 0, 1, 2, 3, 4, or 5, [0371] R.sub.601 may be a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a, Si(Q.sub.601)(Q.sub.602)(Q.sub.603), C(O)(Q.sub.601), S(O).sub.2(Q.sub.601), or P(O)(Q.sub.601)(Q.sub.602), [0372] R.sub.10a may be the same as described in Formula 1, [0373] Q.sub.601 to Q.sub.603 may each independently be the same as described in connection with Q.sub.1, [0374] xe21 may be 1, 2, 3, 4, or 5, and [0375] at least one of Ar.sub.601, L.sub.601, and R.sub.601 may each independently be a electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group that is unsubstituted or substituted with at least one R.sub.10a.
[0376] In an embodiment, in Formula 601, when xe11 is 2 or more, two or more of Ar.sub.601 may be linked together via a single bond.
[0377] In an embodiment, in Formula 601, Ar.sub.601 may be a substituted or unsubstituted anthracene group.
[0378] In an embodiment, the electron transport region may include a compound represented by Formula 601-1:
##STR00187##
[0379] In Formula 601-1, [0380] X.sub.614 may be N or C(R.sub.614), X.sub.615 may be N or C(R.sub.615), X.sub.616 may be N or C(R.sub.616), and at least one of X.sub.614 to X.sub.616 may each be N, [0381] L.sub.611 to L.sub.613 may each independently be the same as described in connection with L.sub.601, [0382] xe611 to xe613 may each independently be the same as described in connection with xe1, [0383] R.sub.611 to R.sub.613 may each independently be the same as described in connection with R.sub.601, and [0384] R.sub.614 to R.sub.616 may each independently be hydrogen, deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.20 alkyl group, a C.sub.1-C.sub.20 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group that is unsubstituted or substituted with at least one R.sub.10a, or a C.sub.1-C.sub.60 heterocyclic group that is unsubstituted or substituted with at least one R.sub.10a.
[0385] In an embodiment, in Formulae 601 and 601-1, xe1 and xe611 to xe613 may each independently be 0, 1, or 2.
[0386] In an embodiment, the electron transport region may include one of Compounds ET1 to ET45, 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (BCP), 4,7-diphenyl-1,10-phenanthroline (Bphen), Alq.sub.3, BAIq, TAZ, NTAZ, TSPO1, TPBI, or any combination thereof:
##STR00188## ##STR00189## ##STR00190## ##STR00191## ##STR00192## ##STR00193## ##STR00194## ##STR00195## ##STR00196## ##STR00197## ##STR00198## ##STR00199## ##STR00200## ##STR00201## ##STR00202## ##STR00203##
[0387] A thickness of the electron transport region may be in a range of about 100 to about 5,000 . For example, the thickness of the electron transport region may be in a range of about 160 to about 4,000 . In cases where the electron transport region includes a buffer layer, a hole blocking layer, an electron control layer, an electron transport layer, or any combination thereof, a thickness of the buffer layer, the hole blocking layer, or the electron control layer may be each independently be in a range of about 20 to about 1,000 , and a thickness of the electron transport layer may be in a range of about 100 to about 1,000 . For example, the thickness of the buffer layer, the hole blocking layer, or the electron control layer may each independently be in a range of about 30 to about 300 . For example, the thickness of the electron transport layer may be in a range of about 150 to about 500 . In cases where the thicknesses of the buffer layer, the hole blocking layer, the electron control layer, the electron transport layer, and/or the electron transport region are within these ranges, satisfactory electron transport characteristics may be obtained without a substantial increase in driving voltage.
[0388] The electron transport region (for example, the electron transport layer in the electron transport region) may further include a metal-containing material in addition to the materials described above.
[0389] The metal-containing material may include an alkali metal complex, an alkaline earth metal complex, or any combination thereof. A metal ion in the alkali metal complex may be a Li ion, a Na ion, a K ion, a Rb ion, or a Cs ion, and a metal ion in the alkaline earth metal complex may be a Be ion, a Mg ion, a Ca ion, a Sr ion, or a Ba ion. A ligand coordinated with the metal ion of the alkali metal complex or the alkaline earth-metal complex may include a hydroxyquinoline, a hydroxyisoquinoline, a hydroxybenzoquinoline, a hydroxyacridine, a hydroxyphenanthridine, a hydroxyphenyloxazole, a hydroxyphenylthiazole, a hydroxyphenyloxadiazole, a hydroxyphenylthiadiazole, a hydroxyphenylpyridine, a hydroxyphenylbenzimidazole, a hydroxyphenylbenzothiazole, a bipyridine, a phenanthroline, a cyclopentadiene, or any combination thereof.
[0390] In an embodiment, the metal-containing material may include a Li complex. The Li complex may include, for example, Compound ET-D1 (LiQ) or ET-D2:
##STR00204##
[0391] The electron transport region may include an electron injection layer that facilitates the injection of electrons from the second electrode 150. The electron injection layer may contact (e.g., directly contact) the second electrode 150.
[0392] The electron injection layer may have a structure consisting of a layer consisting of a single material, a structure consisting of a layer including different materials, or a structure including multiple layers including different materials.
[0393] The electron injection layer may include an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal-containing compound, an alkaline earth metal-containing compound, a rare earth metal-containing compound, an alkali metal complex, an alkaline earth metal complex, a rare earth metal complex, or any combination thereof.
[0394] The alkali metal may include Li, Na, K, Rb, Cs, or any combination thereof. The alkaline earth metal may include Mg, Ca, Sr, Ba, or any combination thereof. The rare earth metal may include Sc, Y, Ce, Tb, Yb, Gd, or any combination thereof.
[0395] The alkali metal-containing compound, the alkaline earth metal-containing compound, and the rare earth metal-containing compound may include oxides, halides (for example, fluorides, chlorides, bromides, iodides, etc.), or tellurides of the alkali metal, the alkaline earth metal, or the rare earth metal, or any combination thereof.
[0396] The alkali metal-containing compound may include: alkali metal oxides, such as Li.sub.2O, Cs.sub.2O, or K.sub.2O; alkali metal halides, such as LiF, NaF, CsF, KF, LiI, NaI, CsI, or Kl; or any combination thereof. The alkaline earth metal-containing compound may include an alkaline earth metal oxide, such as BaO, SrO, CaO, Ba.sub.xSr.sub.1-xO (where x is a real number satisfying 0<x<1), or Ba.sub.xCa.sub.1-xO (where x is a real number satisfying 0<x<1). The rare earth metal-containing compound may include YbF.sub.3, ScF.sub.3, Sc.sub.2O.sub.3, Y.sub.2O.sub.3, Ce.sub.2O.sub.3, GdF.sub.3, TbF.sub.3, YbI.sub.3, ScI.sub.3, TbI.sub.3, or any combination thereof. In an embodiment, the rare earth metal-containing compound may include a lanthanide metal telluride. Examples of the lanthanide metal telluride may include LaTe, CeTe, PrTe, NdTe, PmTe, SmTe, EuTe, GdTe, TbTe, DyTe, HoTe, ErTe, TmTe, YbTe, LuTe, La.sub.2Te.sub.3, Ce.sub.2Te.sub.3, Pr.sub.2Te.sub.3, Nd.sub.2Te.sub.3, Pm.sub.2Te.sub.3, Sm.sub.2Te.sub.3, Eu.sub.2Te.sub.3, Gd.sub.2Te.sub.3, Tb.sub.2Te.sub.3, Dy.sub.2Te.sub.3, Ho.sub.2Te.sub.3, Er.sub.2Te.sub.3, Tm.sub.2Te.sub.3, Yb.sub.2Te.sub.3, and Lu.sub.2Te.sub.3.
[0397] The alkali metal complex, the alkaline earth-metal complex, and the rare earth metal complex may include alkali metal ions, alkaline earth metal ions, or rare earth metal ions; and a ligand bonded to each metal ion, for example, hydroxyquinoline, hydroxyisoquinoline, hydroxybenzoquinoline, hydroxyacridine, hydroxyphenanthridine, hydroxyphenyloxazole, hydroxyphenylthiazole, hydroxyphenyloxadiazole, hydroxyphenylthiadiazole, hydroxyphenylpyridine, hydroxyphenyl benzimidazole, hydroxyphenylbenzothiazole, bipyridine, phenanthroline, cyclopentadiene, or any combination thereof.
[0398] In an embodiment, the electron injection layer may consist of an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal-containing compound, an alkaline earth metal-containing compound, a rare earth metal-containing compound, an alkali metal complex, an alkaline earth metal complex, a rare earth metal complex, or any combination thereof, as described above. In an embodiment, the electron injection layer may further include an organic material (for example, a compound represented by Formula 601).
[0399] In an embodiment, the electron injection layer may consist of an alkali metal-containing compound (for example, alkali metal halide); or the electron injection layer may consist of an alkali metal-containing compound (for example, alkali metal halide), and an alkali metal, an alkaline earth metal, a rare earth metal, or any combination thereof. For example, the electron injection layer may be a Kl:Yb co-deposited layer, an RbI:Yb co-deposited layer, etc.
[0400] In cases where the electron injection layer further includes an organic material, an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal-containing compound, an alkaline earth metal-containing compound, a rare earth metal-containing compound, an alkali metal complex, an alkaline earth-metal complex, a rare earth metal complex, or any combination thereof may be uniformly or non-uniformly dispersed in a matrix that includes the organic material.
[0401] A thickness of the electron injection layer may be in a range of about 1 to about 100 . For example, the thickness of the electron injection layer may be in a range of about 3 to about 90 . In cases where the thickness of the electron injection layer is within any of the ranges described above, satisfactory electron injection characteristics may be obtained without a substantial increase in driving voltage.
[Second Electrode 150]
[0402] The second electrode 150 may be arranged on the interlayer 130. The second electrode 150 may be a cathode, which is an electron injection electrode. In cases where the second electrode 150 is a cathode, the second electrode 150 may include a material having a low-work function, such as a metal, an alloy, an electrically conductive compound, or any combination thereof.
[0403] The second electrode 150 may include lithium (Li), silver (Ag), magnesium (Mg), aluminum (Al), aluminum-lithium (AlLi), calcium (Ca), magnesium-indium (MgIn), magnesium-silver (MgAg), ytterbium (Yb), silver-ytterbium (AgYb), ITO, IZO, or any combination thereof. The second electrode 150 may be a transmissive electrode, a transflective electrode, or a reflective electrode.
[0404] The second electrode 150 may have a single-layer structure or a multilayer structure.
[Capping Layer]
[0405] The light-emitting device 10 may include a first capping layer and/or a second capping layer. The first capping layer may be arranged outside the first electrode 110, and the second capping layer may be arranged outside the second electrode 150. In an embodiment, the light-emitting device 10 may have a structure in which the first capping layer, the first electrode 110, the interlayer 130, and the second electrode 150 are stacked in the stated order, a structure in which the first electrode 110, the interlayer 130, the second electrode 150, and the second capping layer are stacked in the stated order, or a structure in which the first capping layer, the first electrode 110, the interlayer 130, the second electrode 150, and the second capping layer are stacked in the stated order.
[0406] Light generated in the emission layer of the interlayer 130 in the light-emitting device 10 may be extracted to the outside through the first electrode 110, which is a transflective electrode or a transmissive electrode, and the first capping layer. Light generated in the emission layer of the interlayer 130 in the light-emitting device 10 may be extracted to the outside through the second electrode 150, which is also a transflective electrode or a transmissive electrode, and the second capping layer.
[0407] The first capping layer and the second capping layer may increase external emission efficiency through the principle of constructive interference. Accordingly, the light extraction efficiency of the light-emitting device 10 may be improved, thereby increasing the luminescence efficiency of the light-emitting device 10.
[0408] Each of the first capping layer and the second capping layer may include a material having a refractive index of about 1.6 or higher (measured at a wavelength of about 589 nm).
[0409] The first capping layer and the second capping layer may each independently be an organic capping layer including an organic material, an inorganic capping layer including an inorganic material, or an organic-inorganic composite capping layer including both an organic material and an inorganic material.
[0410] At least one of the first capping layer and the second capping layer may each independently include a carbocyclic compound, a heterocyclic compound, an amine group-containing compound, a porphine derivative, a phthalocyanine derivative, a naphthalocyanine derivative, an alkali metal complex, an alkaline earth metal complex, or any combination thereof. The carbocyclic compound, the heterocyclic compound, and the amine group-containing compound may optionally be substituted with a substituent including O, N, S, Se, Si, F, Cl, Br, I, or any combination thereof. In an embodiment, at least one of the first capping layer and the second capping layer may each independently include an amine group-containing compound.
[0411] In an embodiment, at least one of the first capping layer and the second capping layer may each independently include a compound represented by Formula 201, a compound represented by Formula 202, or any combination thereof.
[0412] In an embodiment, at least one of the first capping layer and the second capping layer may each independently include one of Compounds HT28 to HT33, one of Compounds CP1 to CP6, -NPB, or any combination thereof:
##STR00205## ##STR00206##
[Film]
[0413] The organometallic compound represented by Formula 1 may be included in various films.
[0414] Thus, according to embodiments, a film may include the organometallic compound represented by Formula 1. The film may be, for example, an optical member (or a light control means) (for example, a color filter, a color conversion member, a capping layer, a light extraction efficiency enhancement layer, a selective light absorbing layer, a polarizing layer, a quantum dot-containing layer, or like), a light-blocking member (for example, a light reflective layer, a light absorbing layer, or the like), or a protective member (for example, an insulating layer, a dielectric layer, or the like).
[Electronic Apparatus]
[0415] The light-emitting device may be included in various electronic apparatuses. For example, an electronic apparatus including the light-emitting device may be a light-emitting apparatus, an authentication apparatus, and the like.
[0416] The electronic apparatus (for example, a light-emitting apparatus) may further include, in addition to the light-emitting device, a color filter, a color conversion layer, or both a color filter and a color conversion layer. The color filter and/or the color conversion layer may be arranged in at least one direction of travel of light emitted from the light-emitting device. For example, the light emitted from the light-emitting device may be blue light or white light. A detailed description of the light-emitting device may be as provided herein. In an embodiment, the color conversion layer may include quantum dots. The quantum dots may be, for example, the quantum dots described herein.
[0417] The electronic apparatus may include a substrate. The substrate may include subpixels, the color filter may include color filter areas respectively corresponding to the subpixels, and the color conversion layer may include color conversion areas respectively corresponding to the subpixels.
[0418] A pixel-defining film may be arranged between the subpixels to define each subpixel.
[0419] The color filter may further include color filter areas and light-shielding patterns arranged between the color filter areas, and the color conversion layer may further include color conversion areas and light-shielding patterns arranged between the color conversion areas.
[0420] The color filter areas (or the color conversion areas) may include a first area emitting first color light, a second area emitting second color light, and/or a third area emitting third color light, where the first color light, the second color light, and/or the third color light may have different maximum emission wavelengths from one another. In an embodiment, the first color light may be red light, the second color light may be green light, and the third color light may be blue light. In an embodiment, the color filter areas (or the color conversion areas) may include quantum dots. In an embodiment, the first area may include red quantum dots, the second area may include green quantum dots, and the third area may not include quantum dots. A detailed description of the quantum dots may be the same as provided herein. The first area, the second area, and/or the third area may each further include a scatterer.
[0421] In an embodiment, the light-emitting device may emit first light, the first area may absorb the first light to emit first-1 color light, the second area may absorb the first light to emit second-1 color light, and the third area may absorb the first light to emit third-1 color light. The first-1 color light, the second-1 color light, and the third-1 color light may each have different maximum emission wavelengths. In an embodiment, the first light may be blue light, the first-1 color light may be red light, the second-1 color light may be green light, and the third-1 color light may be blue light.
[0422] The electronic apparatus may further include a thin-film transistor, in addition to the light-emitting device as described above. The thin-film transistor may include a source electrode, a drain electrode, and an active layer, where one of the source electrode and the drain electrode may be electrically connected to the first electrode or the second electrode of the light-emitting device.
[0423] The thin-film transistor may further include a gate electrode, a gate insulating film, or the like.
[0424] The active layer may include crystalline silicon, amorphous silicon, an organic semiconductor, an oxide semiconductor, and the like.
[0425] The electronic apparatus may further include a sealing portion that seals the light-emitting device. The sealing portion may be arranged between the color filter and/or the color conversion layer and the light-emitting device. The sealing portion may allow light from the light-emitting device to be extracted to the outside, and simultaneously prevent ambient air and/or moisture from penetrating into the light-emitting device. The sealing portion may be a sealing substrate including a transparent glass substrate or a plastic substrate. The sealing portion may be a thin-film encapsulation layer including at least one of an organic layer and/or an inorganic layer. In cases where the sealing portion is a thin-film encapsulation layer, the electronic apparatus may be flexible.
[0426] Various functional layers may be further included on the sealing portion, in addition to the color filter and/or the color conversion layer, depending on the use of the electronic apparatus. Examples of the functional layers may include a touch screen layer and a polarizing layer. The touch screen layer may be, for example, a pressure-sensitive touch screen layer, a capacitive touch screen layer, or an infrared touch screen layer. The authentication apparatus may be, for example, a biometric authentication apparatus that authenticates an individual using biometric information of a living body (for example, fingertips, pupils, etc.).
[0427] The authentication apparatus may further include, in addition to the light-emitting device as described above, a biometric information collector.
[0428] The electronic apparatus may be applied to various displays, light sources, lighting, personal computers (for example, a mobile personal computer), mobile phones, digital cameras, electronic organizers, electronic dictionaries, electronic game machines, medical instruments (for example, electronic thermometers, sphygmomanometers, blood glucose meters, pulse measurement devices, pulse wave measurement devices, electrocardiogram displays, ultrasonic diagnostic devices, or endoscope displays), fish finders, measuring instruments, meters (for example, meters for a vehicle, an aircraft, and a vessel), projectors, and the like.
[Electronic Equipment]
[0429] The light-emitting device may be included in various types of electronic equipment.
[0430] Examples of electronic equipment that include the light-emitting device may be a flat panel display, a curved display, a computer monitor, a medical monitor, a television, an advertisement board, an indoor light, an outdoor light, a signal light, a head-up display, a fully transparent display, a partially transparent display, a flexible display, a rollable display, a foldable display, a stretchable display, a laser printer, a telephone, a mobile phone, a tablet computer, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a microdisplay, a three-dimensional (3D) display, a virtual reality display, an augmented reality display, a vehicle, a video wall with multiple displays tiled together, a theater screen, a stadium screen, and a phototherapy device, or a signboard.
[0431] The light-emitting device can offer excellent luminescence efficiency and along lifespan, allowing the electronic equipment that includes the light-emitting device to produce high luminance, high resolution, and low power consumption.
[Description of FIGS. 2 and 3]
[0432]
[0433] The electronic apparatus of
[0434] The substrate 100 may be a flexible substrate, a glass substrate, or a metal substrate. A buffer layer 210 may be disposed on the substrate 100. The buffer layer 210 may prevent penetration of impurities through the substrate 100 and may provide a flat surface on the substrate 100.
[0435] A TFT may be arranged on the buffer layer 210. The TFT may include an active layer 220, a gate electrode 240, a source electrode 260, and a drain electrode 270.
[0436] The active layer 220 may include an inorganic semiconductor, such as silicon or polysilicon, an organic semiconductor, or an oxide semiconductor, and may include a source region, a drain region, and a channel region.
[0437] A gate insulating film 230, which insulates the active layer 220 from the gate electrode 240, may be arranged on the active layer 220, and the gate electrode 240 may be arranged on the gate insulating film 230.
[0438] An interlayer insulating film 250 may be arranged on the gate electrode 240. The interlayer insulating film 250 may be arranged between the gate electrode 240 and the source electrode 260, and between the gate electrode 240 and the drain electrode 270, to insulate these components from one another.
[0439] The source electrode 260 and the drain electrode 270 may be arranged on the interlayer insulating film 250. The interlayer insulating film 250 and the gate insulating film 230 may be formed to expose the source region and the drain region of the active layer 220, allowing the source electrode 260 and the drain electrode 270 to be in contact with the exposed portions of the source region and the drain region of the active layer 220, respectively.
[0440] The TFT may be electrically connected to a light-emitting device to drive the light-emitting device and may be covered and protected by a passivation layer 280. The passivation layer 280 may include an inorganic insulating film, an organic insulating film, or any combination thereof. A light-emitting device may be provided on the passivation layer 280. The light-emitting device may include a first electrode 110, an interlayer 130, and a second electrode 150.
[0441] The first electrode 110 may be arranged on the passivation layer 280. The passivation layer 280 may partially expose a portion of the drain electrode 270, leaving part of the drain electrode 270 uncovered. The first electrode 110 may be connected (e.g., electrically connected) to the exposed portion of the drain electrode 270.
[0442] A pixel-defining film 290, including an insulating material, may be arranged on the first electrode 110. The pixel-defining film 290 may expose a region of the first electrode 110, where the interlayer 130 may be formed in the exposed region of the first electrode 110. The pixel-defining film 290 may be a polyimide-based organic film or a polyacrylic organic film. Although not shown in
[0443] The second electrode 150 may be arranged on the interlayer 130, and a capping layer 170 may be further included on the second electrode 150. The capping layer 170 may cover the second electrode 150.
[0444] The encapsulation portion 300 may be located on the capping layer 170. The encapsulation portion 300 may be disposed over a light-emitting device to protect the light-emitting device from moisture and/or oxygen. The encapsulation portion 300 may include: an inorganic film including silicon nitride (SiN.sub.x), silicon oxide (SiO.sub.x), indium tin oxide, indium zinc oxide, or any combination thereof; an organic film including polyethylene terephthalate, polyethylene naphthalate, polycarbonate, polyimide, polyethylene sulfonate, polyoxymethylene, polyarylate, hexamethyldisiloxane, an acrylic resin (for example, polymethyl methacrylate, polyacrylic acid, or the like), an epoxy-based resin (for example, aliphatic glycidyl ether (AGE), or the like), or any combination thereof; or any combination of the inorganic film and the organic film.
[0445]
[0446] The electronic apparatus of
[Description of FIG. 4]
[0447]
[0448] The electronic equipment 1 may be a portable electronic device used to display a moving image or a still image, such as a mobile phone, a smartphone, a tablet computer, a mobile communication terminal, an electronic notebook, an electronic book, a portable multimedia player (PMP), a navigation device, or an ultra-mobile personal computer (UMPC). The electronic equipment 1 may also refer to various other products, such as a television, a laptop, a monitor, a billboard, or an Internet of things (IoT) device. The electronic equipment 1 may be one of these products or a component thereof.
[0449] In an embodiment, the electronic equipment 1 may be a wearable device, such as a smart watch, a watch phone, a glasses-type display, or a head mounted display (HMD), or a part of the wearable device. However, embodiments are not limited thereto.
[0450] In an embodiment, the electronic equipment 1 may be a dashboard of a vehicle, a center information display (CID) on a center fascia or dashboard of a vehicle, a room mirror display replacing a side-view mirror of a vehicle, a rear-seat entertainment display of a vehicle, or a display on the back of a front seat, a head up display (HUD) installed at the front of a vehicle or projected onto a windshield, or a computer generated hologram augmented reality head up display (CGH AR HUD). For convenience of explanation,
[0451] The electronic equipment 1 may include a display area DA and a non-display area NDA surrounding the display area DA. A display apparatus may produce an image through an array of multiple pixels arranged two-dimensionally in the display area DA.
[0452] The non-display area NDA, which does not display an image, may surround (e.g., entirely surround) the display area DA. A driver for providing electrical signals or power to the display devices in the display area DA may be arranged in the non-display area NDA. A pad for electrically connecting an electronic element or a printed circuit board may be arranged in the non-display area NDA.
[0453] In the electronic equipment 1, the length in an x-axis direction and the length in a y-axis direction may be different from each other. In an embodiment, as shown in
[Description of FIGS. 5 and 6A to 6C]
[0454]
[0455] Referring to
[0456] The vehicle 1000 may travel on a road or a track. The vehicle 1000 may move in a direction based on rotation of at least one wheel. Examples of the vehicle 1000 may include a three-wheeled or four-wheeled vehicle, a construction machine, a two-wheeled vehicle, a prime mover device, a bicycle, and a train running on a track.
[0457] The vehicle 1000 may include a body having an interior and an exterior, and a chassis containing mechanical components necessary for driving, excluding the body. The exterior of the body may include, but is not limited to, a front panel, a bonnet, a roof panel, a rear panel, a trunk, a pillar provided at a boundary between doors, and the like. The chassis of the vehicle 1000 may include, but is not limited to, a power generating device, a power transmitting device, a driving device, a steering device, a braking device, a suspension device, a transmission device, a fuel device, front and rear wheels, left and right wheels, and the like.
[0458] The vehicle 1000 may include a side window glass 1100, a windshield 1200, a side-view mirror 1300, a cluster 1400, a center fascia 1500, a passenger seat dashboard 1600, and a display apparatus 2.
[0459] The side window glass 1100 and the front window glass 1200 may be partitioned by a pillar arranged between the side window glass 1100 and the front window glass 1200.
[0460] The side window glass 1100 may be installed on a side of the vehicle 1000. In an embodiment, the side window glass 1100 may be installed on a door of the vehicle 1000. Multiple side window glasses 1100 may be provided and may face each other. In an embodiment, the side window glass 1100 may include a first side window glass 1110 and a second side window glass 1120. In an embodiment, the first side window glass 1110 may be arranged adjacent to the cluster 1400, and the second side window glass 1120 may be arranged adjacent to the passenger seat dashboard 1600.
[0461] In an embodiment, the side window glasses 1100 may be spaced apart from each other in an x direction or a x direction. In an embodiment, the first side window glass 1110 and the second side window glass 1120 may similarly be spaced apart from each other in the x direction or the x direction. For example, an imaginary straight line L connecting the side window glasses 1100 may extend in the x direction or the x direction. In an embodiment, an imaginary straight line L connecting the first side window glass 1110 and the second side window glass 1120 to each other may extend in the x direction or the x direction.
[0462] The front window glass 1200 may be installed at a front of the vehicle 1000. The front window glass 1200 may be arranged between the side window glasses 1100 facing each other.
[0463] The side-view mirror 1300 may provide a rear view of the vehicle 1000. The side-view mirror 1300 may be installed on the exterior of the body. In an embodiment, multiple side-view mirrors 1300 may be provided. For example, one of the side-view mirrors 1300 may be arranged outside the first side window glass 1110 and another of the side-view mirrors 1300 may be arranged outside the second side window glass 1120.
[0464] The cluster 1400 may be arranged in front of a steering wheel. The cluster 1400 may include, but is not limited to, a tachometer, a speedometer, a coolant thermometer, a fuel gauge, a turn signal indicator, a high beam indicator, a warning light, a seat belt warning light, an odometer, a tachograph, an automatic shift selector indicator light, a door open warning light, an engine oil warning light, and/or a low fuel warning light.
[0465] The center fascia 1500 may include a control panel on which buttons for adjusting an audio device, an air conditioning device, and a seat heater are disposed. The center fascia 1500 may be arranged on a side of the cluster 1400.
[0466] The center fascia 1500 may be arranged between the cluster 1400 and the passenger seat dashboard 1600. In an embodiment, the cluster 1400 may be arranged to correspond to a driver seat (not shown), and the passenger seat dashboard 1600 may be arranged to correspond to a passenger seat (not shown). In an embodiment, the cluster 1400 may be adjacent to the first side window glass 1110, and the passenger seat dashboard 1600 may be adjacent to the second side window glass 1120.
[0467] In an embodiment, the display apparatus 2 may include a display panel 3 that displays an image. The display apparatus 2 may be arranged inside the vehicle 1000. In an embodiment, the display apparatus 2 may be arranged between the opposing side window glasses 1100. The display apparatus 2 may be arranged on at least one of the cluster 1400, the center fascia 1500, and the passenger seat dashboard 1600.
[0468] The display apparatus 2 may include an organic light-emitting display, an inorganic electroluminescent display, a quantum dot display, or the like. Hereinafter, an organic light-emitting display apparatus including the light-emitting device will be described as an example of the display apparatus 2. However, various types of display apparatuses as described above may be used in embodiments.
[0469] Referring to
[0470] Referring to
[0471] Referring to
[Manufacturing Method]
[0472] The layers forming the hole transport region, the emission layer, and the electron transport region may be produced in a selected region using various methods, such as vacuum deposition, spin coating, casting, Langmuir-Blodgett (LB) deposition, ink-jet printing, laser printing, laser-induced thermal imaging, and the like.
[0473] In cases where the layers for the hole transport region, the emission layer, and the electron transport region are produced by vacuum deposition, the deposition may be performed at a deposition temperature in a range of about 100 C. to about 500 C., at a vacuum level in a range of about 10.sup.8 torr to about 10.sup.3 torr, and at a deposition speed in a range of about 0.01 /sec to about 100 /sec, depending on a material to be included in a layer to be formed and the structure of a layer to be formed.
Definition of Terms
[0474] The term C.sub.3-C.sub.60 carbocyclic group as used herein may be a cyclic group consisting of carbon atoms as the only ring-forming atoms and having three to sixty carbon atoms, and the term C.sub.1-C.sub.60 heterocyclic group as used herein may be a cyclic group that has one to sixty carbon atoms and further includes, in addition to a carbon atom, at least one heteroatom as a ring-forming atom. The C.sub.3-C.sub.60 carbocyclic group and the C.sub.1-C.sub.60 heterocyclic group may each be a monocyclic group consisting of one ring or a polycyclic group in which two or more rings are condensed with each other. In an embodiment, the C.sub.1-C.sub.60 heterocyclic group may have 3 to 61 ring-forming atoms.
[0475] The term cyclic group as used herein may be a C.sub.3-C.sub.60 carbocyclic group or a C.sub.1-C.sub.60 heterocyclic group.
[0476] The term electron-rich C.sub.3-C.sub.60 cyclic group as used herein may be a cyclic group that has three to sixty carbon atoms and may not include *N* as a ring-forming moiety, and the term electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group as used herein may be a heterocyclic group that has one to sixty carbon atoms and may include *N* as a ring-forming moiety.
[0477] In an embodiment, [0478] a C.sub.3-C.sub.60 carbocyclic group may be a T1 group or a group in which two or more T1 groups are condensed with each other (for example, a cyclopentadiene group, an adamantane group, a norbornane group, a benzene group, a pentalene group, a naphthalene group, an azulene group, an indacene group, an acenaphthylene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a triphenylene group, a pyrene group, a chrysene group, a perylene group, a pentaphene group, a heptalene group, a naphthacene group, a picene group, a hexacene group, a pentacene group, a rubicene group, a coronene group, an ovalene group, an indene group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, an indenophenanthrene group, or an indenoanthracene group), [0479] a C.sub.1-C.sub.60 heterocyclic group may be a T2 group, a group in which two or more T2 groups are condensed with each other, or a group in which at least one T2 group and at least one T1 group are condensed with each other (for example, a pyrrole group, a thiophene group, a furan group, an indole group, a benzoindole group, a naphthoindole group, an isoindole group, a benzoisoindole group, a naphthoisoindole group, a benzosilole group, a benzothiophene group, a benzofuran group, a carbazole group, a dibenzosilole group, a dibenzothiophene group, a dibenzofuran group, an indenocarbazole group, an indolocarbazole group, a benzofurocarbazole group, a benzothienocarbazole group, a benzosilolocarbazole group, a benzoindolocarbazole group, a benzocarbazole group, a benzonaphthofuran group, a benzonaphthothiophene group, a benzonaphthosilole group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienodibenzothiophene group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzoisoxazole group, a benzothiazole group, a benzoisothiazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a benzoisoquinoline group, a quinoxaline group, a benzoquinoxaline group, a quinazoline group, a benzoquinazoline group, a phenanthroline group, a cinnoline group, a phthalazine group, a naphthyridine group, an imidazopyridine group, an imidazopyrimidine group, an imidazotriazine group, an imidazopyrazine group, an imidazopyridazine group, an azacarbazole group, an azafluorene group, an azadibenzosilole group, an azadibenzothiophene group, an azadibenzofuran group, etc.), [0480] a electron-rich C.sub.3-C.sub.60 cyclic group may be a T1 group, a group in which two or more T1 groups are condensed with each other, a T3 group, a group in which two or more T3 groups are condensed with each other, or a group in which at least one T3 group and at least one T1 group are condensed with each other (for example, a C.sub.3-C.sub.60 carbocyclic group, a 1H-pyrrole group, a silole group, a borole group, a 2H-pyrrole group, a 3H-pyrrole group, a thiophene group, a furan group, an indole group, a benzoindole group, a naphthoindole group, an isoindole group, a benzoisoindole group, a naphthoisoindole group, a benzosilole group, a benzothiophene group, a benzofuran group, a carbazole group, a dibenzosilole group, a dibenzothiophene group, a dibenzofuran group, an indenocarbazole group, an indolocarbazole group, a benzofurocarbazole group, a benzothienocarbazole group, a benzosilolocarbazole group, a benzoindolocarbazole group, a benzocarbazole group, a benzonaphthofuran group, a benzonaphthothiophene group, a benzonaphthosilole group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienodibenzothiophene group, or the like), [0481] a electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group may be a T4 group, a group in which two or more T4 groups are condensed with each other, a group in which at least one T4 group and at least one T1 group are condensed with each other, a group in which at least one T4 group and at least one T3 group are condensed with each other, or v) a group in which at least one T4 group, at least one T1 group, and at least one T3 group are condensed with one another (for example, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzoisoxazole group, a benzothiazole group, a benzoisothiazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a benzoquinoline group, a benzoisoquinoline group, a quinoxaline group, a benzoquinoxaline group, a quinazoline group, a benzoquinazoline group, a phenanthroline group, a cinnoline group, a phthalazine group, a naphthyridine group, an imidazopyridine group, an imidazopyrimidine group, an imidazotriazine group, an imidazopyrazine group, an imidazopyridazine group, an azacarbazole group, an azafluorene group, an azadibenzosilole group, an azadibenzothiophene group, an azadibenzofuran group, and the like), [0482] a T1 group may be a cyclopropane group, a cyclobutane group, a cyclopentane group, a cyclohexane group, a cycloheptane group, a cyclooctane group, a cyclobutene group, a cyclopentene group, a cyclopentadiene group, a cyclohexene group, a cyclohexadiene group, a cycloheptene group, an adamantane group, a norbornane (or bicyclo[2.2.1]heptane) group, a norbornene group, a bicyclo[1.1.1]pentane group, a bicyclo[2.1.1]hexane group, a bicyclo[2.2.2]octane group, or a benzene group, [0483] a T2 group may be a furan group, a thiophene group, a 1H-pyrrole group, a silole group, a borole group, a 2H-pyrrole group, a 3H-pyrrole group, an imidazole group, a pyrazole group, a triazole group, a tetrazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, an azasilole group, an azaborole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a tetrazine group, a pyrrolidine group, an imidazolidine group, a dihydropyrrole group, a piperidine group, a tetrahydropyridine group, a dihydropyridine group, a hexahydropyrimidine group, a tetrahydropyrimidine group, a dihydropyrimidine group, a piperazine group, a tetrahydropyrazine group, a dihydropyrazine group, a tetrahydropyridazine group, or a dihydropyridazine group, [0484] a T3 group may be a furan group, a thiophene group, a 1H-pyrrole group, a silole group, or a borole group, and [0485] a T4 group may be a 2H-pyrrole group, a 3H-pyrrole group, an imidazole group, a pyrazole group, a triazole group, a tetrazole group, an oxazole group, an isoxazole group, an oxadiazole group, a thiazole group, an isothiazole group, a thiadiazole group, an azasilole group, an azaborole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, or a tetrazine group.
[0486] The terms cyclic group, C.sub.3-C.sub.60 carbocyclic group, C.sub.1-C.sub.60 heterocyclic group, electron-rich C.sub.3-C.sub.60 cyclic group, and electron-deficient nitrogen-containing C.sub.1-C.sub.60 cyclic group as used herein may each be a group condensed to any cyclic group, a monovalent group, or a polyvalent group (for example, a divalent group, a trivalent group, a tetravalent group, etc.) according to the structure of a formula for which the corresponding term is used. For example, a benzene group may be a benzo group, a phenyl group, a phenylene group, or the like, which may be readily understood by those of ordinary skill in the art according to the structure of a formula including the benzene group.
[0487] Examples of a monovalent C.sub.3-C.sub.60 carbocyclic group or a monovalent C.sub.1-C.sub.60 heterocyclic group may include a C.sub.3-C.sub.10 cycloalkyl group, a C.sub.1-C.sub.10 heterocycloalkyl group, a C.sub.3-C.sub.10 cycloalkenyl group, a C.sub.1-C.sub.10 heterocycloalkenyl group, a C.sub.6-C.sub.60 aryl group, a C.sub.1-C.sub.60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group.
[0488] Examples of a divalent C.sub.3-C.sub.60 carbocyclic group or a divalent C.sub.1-C.sub.60 heterocyclic group may include a C.sub.3-C.sub.10 cycloalkylene group, a C.sub.1-C.sub.10 heterocycloalkylene group, a C.sub.3-C.sub.10 cycloalkenylene group, a C.sub.1-C.sub.10 heterocycloalkenylene group, a C.sub.6-C.sub.60 arylene group, a C.sub.1-C.sub.60 heteroarylene group, a divalent non-aromatic condensed polycyclic group, and a divalent non-aromatic condensed heteropolycyclic group.
[0489] The term C.sub.1-C.sub.60 alkyl group as used herein may be a linear or branched monovalent aliphatic hydrocarbon group that has one to sixty carbon atoms, and examples thereof may include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a sec-butyl group, an isobutyl group, a tert-butyl group, an n-pentyl group, a tert-pentyl group, a neopentyl group, an isopentyl group, a sec-pentyl group, a 3-pentyl group, a sec-isopentyl group, an n-hexyl group, an isohexyl group, a sec-hexyl group, a tert-hexyl group, an n-heptyl group, an isoheptyl group, a sec-heptyl group, a tert-heptyl group, an n-octyl group, an isooctyl group, a sec-octyl group, a tert-octyl group, an n-nonyl group, an isononyl group, a sec-nonyl group, a tert-nonyl group, an n-decyl group, an isodecyl group, a sec-decyl group, and a tert-decyl group. The term C.sub.1-C.sub.60 alkylene group as used herein may be a divalent group having a same structure as the C.sub.1-C.sub.60 alkyl group.
[0490] The term C.sub.2-C.sub.60 alkenyl group as used herein may be a monovalent hydrocarbon group having at least one carbon-carbon double bond in the middle or at a terminus of the C.sub.2-C.sub.60 alkyl group, and examples thereof may include an ethenyl group, a propenyl group, and a butenyl group. The term C.sub.2-C.sub.60 alkenylene group as used herein may be a divalent group having a same structure as the C.sub.2-C.sub.60 alkenyl group.
[0491] The term C.sub.2-C.sub.60 alkynyl group as used herein may be a monovalent hydrocarbon group having at least one carbon-carbon triple bond in the middle or at a terminus of the C.sub.2-C.sub.60 alkyl group, and examples thereof may include an ethynyl group and a propynyl group. The term C.sub.2-C.sub.60 alkynylene group as used herein may be a divalent group having a same structure as the C.sub.2-C.sub.60 alkynyl group.
[0492] The term C.sub.1-C.sub.60 alkoxy group as used herein may be a monovalent group represented by O(A.sub.101) (wherein A.sub.101 may be a C.sub.1-C.sub.60 alkyl group), and examples thereof may include a methoxy group, an ethoxy group, and an isopropyloxy group.
[0493] The term C.sub.3-C.sub.10 cycloalkyl group as used herein may be a monovalent saturated hydrocarbon cyclic group having three to ten carbon atoms, and examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group (or bicyclo[2.2.1]heptyl group), a bicyclo[1.1.1]pentyl group, a bicyclo[2.1.1]hexyl group, and a bicyclo[2.2.2]octyl group. The term C.sub.3-C.sub.10 cycloalkylene group as used herein may be a divalent group having a same structure as the C.sub.3-C.sub.10 cycloalkyl group.
[0494] The term C.sub.1-C.sub.10 heterocycloalkyl group as used herein may be a monovalent cyclic group that has one to ten carbon atoms and further includes, in addition to the carbon atoms, at least one heteroatom as a ring-forming atom, and examples thereof may include a 1,2,3,4-oxatriazolidinyl group, a tetrahydrofuranyl group, and a tetrahydrothiophenyl group. The term C.sub.1-C.sub.10 heterocycloalkylene group as used herein may be a divalent group having a same structure as the C.sub.1-C.sub.1 heterocycloalkyl group.
[0495] The term C.sub.3-C.sub.10 cycloalkenyl group as used herein may be a monovalent cyclic group that has three to ten carbon atoms and at least one carbon-carbon double bond in the cyclic structure thereof and no aromaticity, and examples thereof may include a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. The term C.sub.3-C.sub.10 cycloalkenylene group as used herein may be a divalent group having a same structure as the C.sub.3-C.sub.10 cycloalkenyl group.
[0496] The term C.sub.1-C.sub.10 heterocycloalkenyl group as used herein may be a monovalent cyclic group that has one to ten carbon atoms, further includes, in addition to the carbon atoms, at least one heteroatom as a ring-forming atom, and has at least one carbon-carbon double bond in the cyclic structure thereof. Examples of a C.sub.1-C.sub.10 heterocycloalkenyl group may include a 4,5-dihydro-1,2,3,4-oxatriazolyl group, a 2,3-dihydrofuranyl group, and a 2,3-dihydrothiophenyl group. The term C.sub.1-C.sub.10 heterocycloalkenylene group as used herein may be a divalent group having a same structure as the C.sub.1-C.sub.10 heterocycloalkenyl group.
[0497] The term C.sub.6-C.sub.60 aryl group as used herein may be a monovalent group having a carbocyclic aromatic system of six to sixty carbon atoms, and the term C.sub.6-C.sub.60 arylene group as used herein may be a divalent group having a carbocyclic aromatic system of six to sixty carbon atoms. Examples of a C.sub.6-C.sub.60 aryl group may include a phenyl group, a pentalenyl group, a naphthyl group, an azulenyl group, an indacenyl group, an acenaphthyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a perylenyl group, a pentaphenyl group, a heptalenyl group, a naphthacenyl group, a picenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, and an ovalenyl group. When the C.sub.6-C.sub.60 aryl group and the C.sub.6-C.sub.60 arylene group each include two or more rings, the two or more respective rings may be condensed with each other.
[0498] The term C.sub.1-C.sub.60 heteroaryl group as used herein may be a monovalent group having a heterocyclic aromatic system that has one to sixty carbon atoms and further includes, in addition to the carbon atoms, at least one heteroatom as a ring-forming atom. The term C.sub.1-C.sub.60 heteroarylene group as used herein may be a divalent group having a heterocyclic aromatic system that has one to sixty carbon atoms and further includes, in addition to the carbon atoms, at least one heteroatom as a ring-forming atom. Examples of a C.sub.1-C.sub.60 heteroaryl group may include a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, a benzoquinolinyl group, an isoquinolinyl group, a benzoisoquinolinyl group, a quinoxalinyl group, a benzoquinoxalinyl group, a quinazolinyl group, a benzoquinazolinyl group, a cinnolinyl group, a phenanthrolinyl group, a phthalazinyl group, and a naphthyridinyl group. When the C.sub.1-C.sub.60 heteroaryl group and the C.sub.1-C.sub.60 heteroarylene group each include two or more rings, the two or more respective rings may be condensed with each other.
[0499] The term monovalent non-aromatic condensed polycyclic group as used herein may be a monovalent group having two or more rings condensed with each other, only carbon atoms (for example, eight to sixty carbon atoms) as ring-forming atoms, and no aromaticity in its molecular structure when considered as a whole. Examples of a monovalent non-aromatic condensed polycyclic group may include an indenyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, an indenophenanthrenyl group, and an indeno anthracenyl group. The term divalent non-aromatic condensed polycyclic group as used herein may be a divalent group having a same structure as the monovalent non-aromatic condensed polycyclic group.
[0500] The term monovalent non-aromatic condensed heteropolycyclic group as used herein may be a monovalent group that has two or more rings condensed with each other, further includes, in addition to carbon atoms (for example, one to sixty carbon atoms), at least one heteroatom as a ring-forming atom, and has no aromaticity in its molecular structure when considered as a whole. Examples of a monovalent non-aromatic condensed heteropolycyclic group may include a pyrrolyl group, a thiophenyl group, a furanyl group, an indolyl group, a benzoindolyl group, a naphthoindolyl group, an isoindolyl group, a benzoisoindolyl group, a naphthoisoindolyl group, a benzosilolyl group, a benzothiophenyl group, a benzofuranyl group, a carbazolyl group, a dibenzosilolyl group, a dibenzothiophenyl group, a dibenzofuranyl group, an azacarbazolyl group, an azafluorenyl group, an azadibenzosilolyl group, an azadibenzothiophenyl group, an azadibenzofuranyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, a thiadiazolyl group, a benzopyrazolyl group, a benzimidazolyl group, a benzoxazolyl group, a benzothiazolyl group, a benzoxadiazolyl group, a benzothiadiazolyl group, an imidazopyridinyl group, an imidazopyrimidinyl group, an imidazotriazinyl group, an imidazopyrazinyl group, an imidazopyridazinyl group, an indeno carbazolyl group, an indolocarbazolyl group, a benzofurocarbazolyl group, a benzothienocarbazolyl group, a benzosilolocarbazolyl group, a benzoindolocarbazolyl group, a benzocarbazolyl group, a benzonaphthofuranyl group, a benzonaphthothiophenyl group, a benzonaphthosilolyl group, a benzofurodibenzofuranyl group, a benzofurodibenzothiophenyl group, and a benzothienodibenzothiophenyl group. The term divalent non-aromatic condensed heteropolycyclic group as used herein may be a divalent group having a same structure as the monovalent non-aromatic condensed heteropolycyclic group.
[0501] The term C.sub.6-C.sub.60 aryloxy group as used herein may be a group represented by O(A.sub.102) (wherein A.sub.102 may be a C.sub.6-C.sub.60 aryl group), and the term C.sub.6-C.sub.60 arylthio group as used herein may be a group represented by S(A.sub.103) (wherein A.sub.103 may be a C.sub.6-C.sub.60 aryl group).
[0502] The term C.sub.7-C.sub.60 arylalkyl group as used herein may be a group represented by -(A.sub.104)(A.sub.105) (wherein A.sub.104 may be a C.sub.1-C.sub.54 alkylene group, and A.sub.105 may be a C.sub.6-C.sub.59 aryl group), and the term C.sub.2-C.sub.60 heteroarylalkyl group as used herein may be a group represented by -(A.sub.106)(A.sub.107) (wherein A.sub.106 may be a C.sub.1-C.sub.59 alkylene group, and A.sub.107 may be a C.sub.1-C.sub.59 heteroaryl group).
[0503] In the specification, the group R.sub.10a may be: [0504] deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, or a nitro group; [0505] a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, or a C.sub.1-C.sub.60 alkoxy group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 arylalkyl group, a C.sub.2-C.sub.60 heteroarylalkyl group, Si(Q.sub.11)(Q.sub.12)(Q.sub.13), N(Q.sub.11)(Q.sub.12), B(Q.sub.11)(Q.sub.12), C(O)(Q.sub.11), S(O).sub.2(Q.sub.11), P(O)(Q.sub.11)(Q.sub.12), or any combination thereof; [0506] a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 arylalkyl group, or a C.sub.2-C.sub.60 heteroarylalkyl group, each unsubstituted or substituted with deuterium, F, Cl, Br, I, a hydroxyl group, a cyano group, a nitro group, a C.sub.1-C.sub.60 alkyl group, a C.sub.2-C.sub.60 alkenyl group, a C.sub.2-C.sub.60 alkynyl group, a C.sub.1-C.sub.60 alkoxy group, a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.6-C.sub.60 aryloxy group, a C.sub.6-C.sub.60 arylthio group, a C.sub.7-C.sub.60 arylalkyl group, a C.sub.2-C.sub.60 heteroarylalkyl group, Si(Q.sub.21)(Q.sub.22)(Q.sub.23), N(Q.sub.21)(Q.sub.22), B(Q.sub.21)(Q.sub.22), C(O)(Q.sub.21), S(O).sub.2(Q.sub.21), P(O)(Q.sub.21)(Q.sub.22), or any combination thereof; or [0507] Si(Q.sub.31)(Q.sub.32)(Q.sub.33), N(Q.sub.31)(Q.sub.32), B(Q.sub.31)(Q.sub.32), C(O)(Q.sub.31), S(O).sub.2(Q.sub.31), or P(O)(Q.sub.31)(Q.sub.32).
[0508] In the specification, Q.sub.1 to Q.sub.3, Q.sub.11 to Q.sub.13, Q.sub.21 to Q.sub.23, and Q.sub.31 to Q.sub.33 as used herein may each independently be: hydrogen; deuterium; F; Cl; Br; I; a hydroxyl group; a cyano group; a nitro group; a C.sub.1-C.sub.60 alkyl group; a C.sub.2-C.sub.60 alkenyl group; a C.sub.2-C.sub.60 alkynyl group; a C.sub.1-C.sub.60 alkoxy group; or a C.sub.3-C.sub.60 carbocyclic group, a C.sub.1-C.sub.60 heterocyclic group, a C.sub.7-C.sub.60 arylalkyl group, or a C.sub.2-C.sub.60 heteroarylalkyl group, each unsubstituted or substituted with deuterium, F, a cyano group, a C.sub.1-C.sub.60 alkyl group, a C.sub.1-C.sub.60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof.
[0509] The term heteroatom as used herein may be any atom other than a carbon atom or a hydrogen. Examples of a heteroatom may include O, S, N, P, Si, B, Ge, Se, and any combination thereof.
[0510] The term third-row transition metal as used herein may include hafnium (Hf), tantalum (Ta), tungsten (W), rhenium (Re), osmium (Os), iridium (Ir), platinum (Pt), and gold (Au).
[0511] In the specification, the term Ph refers to a phenyl group, the term Me refers to a methyl group, the term Et refers to an ethyl group, the term tert-Bu or Bu.sup.t each refers to a tert-butyl group, and the term OMe refers to a methoxy group.
[0512] The term biphenyl group as used herein may be a phenyl group that is substituted with a phenyl group. For example, the biphenyl group may be a substituted phenyl group having a C.sub.6-C.sub.60 aryl group as a substituent.
[0513] The term terphenyl group as used herein may be a phenyl group substituted with a biphenyl group. The terphenyl group may be a substituted phenyl group having, as a substituent, a C.sub.6-C.sub.60 aryl group substituted with a C.sub.6-C.sub.60 aryl group.
[0514] The symbols * and * as used herein, unless defined otherwise, each refer to a binding site to a neighboring atom in a corresponding formula or moiety.
[0515] In the specification, the terms x-axis, y-axis, and z-axis are not limited to three axes in an orthogonal coordinate system, and may be interpreted in a broader sense than the aforementioned three axes in an orthogonal coordinate system. For example, the x-axis, y-axis, and z-axis may describe axes that are orthogonal to each other, or may describe axes that are not orthogonal to each other.
[0516] Hereinafter, compounds according to embodiments and light-emitting devices according to embodiments will be described in detail with reference to the following synthesis examples and examples. The wording B was used instead of A used in describing Synthesis Examples means that an identical molar equivalent of B was used in place of A.
EXAMPLES
Synthesis Example 1: Synthesis of Compound 7
##STR00207## ##STR00208## ##STR00209##
1) Synthesis of Intermediate 7-1
[0517] 4-bromo-2-fluoropyridine (1.0 eq), 2-methoxy-9H-carbazole-5,6,7-d.sub.3 (2.0 eq), and potassium phosphate (3.0 eq) were dissolved in N,N-dimethylmethanamide (0.01 M) and stirred at 150 C. for 20 hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using methylene chloride (MC) and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:hexane) to synthesize Intermediate 7-1 (yield of 85%).
2) Synthesis of Intermediate 7-2
[0518] Intermediate 7-1 (1.0 eq), 3,6-di-tert-butyl-9H-carbazole (1.2 eq), copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and ()-trans-1,2-diaminocyclohexane (0.10 eq) were dissolved in N,N-dimethylformamide (0.01 M) and stirred at 150 C. for 24 hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 7-2 (yield of 83%).
3) Synthesis of Intermediate 7-3
[0519] After Intermediate 7-2 (1 eq) was dissolved in ortho dichlorobenzene, the flask was cooled to 0 C. under a nitrogen atmosphere, and BI.sub.3 (3 eq) dissolved in ortho dichlorobenzene was slowly injected thereto. After termination of the dropwise addition, the temperature was raised to 140 C., followed by stirring for 16 hours. After cooling to 0 C., triethylamine was slowly added dropwise to the flask to terminate the reaction until the exotherm stopped, and n-hexane and methanol were added thereto and a solid was subjected to filtration and precipitation. The obtained solid was purified by silica filtration and purified again by MC/Hex recrystallization to obtain Intermediate 7-3. Afterwards, final purification was performed using column (dichloromethane: n-hexane) (yield: 63%).
4) Synthesis of Intermediate 7-4
[0520] After Intermediate 7-3 (1.0 eq) was dissolved in dichloromethane (0.01 M), boron tribromide 1.0M dichloromethane (2 eq) was slowly added thereto at 0 C. under a nitrogen atmosphere. The mixed solution was stirred at room temperature for four hours to obtain a reaction product. An extraction process was performed on the reaction product three times by using water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:Hex) to synthesize Intermediate 7-4 (yield of 68%).
5) Synthesis of Intermediate 7-5
[0521] Intermediate 7-4 (1.0 eq), 1-bromo-3-(tert-butyl)-5-chlorobenzene, copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and 2-picolinic acid (0.10 eq) were dissolved in dimethyl sulfoxide (0.01 M) and stirred at 100 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 7-5 (yield of 79%).
6) Synthesis of Intermediate 7-6
[0522] Intermediate 7-5 (1.0 eq), N.sup.1-(3,5-di-tert-butyl-[1,1:3,1-terphenyl]-2-yl-2,3,4,5,6-d.sub.5)benzene-1,2-diamine (1.0 eq), 2-dicyclohexylphosphino-2,4,6-triisopropylbiphenyl (Xphos, 0.10 eq), tris(dibenzylideneacetone)dipalladium(0) (Pd.sub.2(dba).sub.3, 0.05 eq), and sodium tert-butoxide (NaOtBu, 3 eq) were dissolved in 1,4-dioxane and stirred at 110 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 7-6 (yield of 81%).
7) Synthesis of Intermediate 7-7
[0523] After Intermediate 7-6 (1.0 eq) was dissolved in triethyl orthoformate (30 eq), 37% HCl (1.5 eq) was added thereto. The mixed solution was stirred at 80 C. for 18 hours to obtain a reaction product. The reaction product was cooled at room temperature, and triethyl orthoformate in the reaction product was concentrated. An extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:methanol) to synthesize Intermediate 7-7 (yield of 77%).
7) Synthesis of Compound 7
[0524] Intermediate 7-7 (1.0 eq), potassium platinum (II) chloride (1.1 eq), and 2,6-lutidine (4.0 eq) were dissolved in 1,2-dichlorobenzene (0.05 M) and stirred under nitrogen conditions at 120 C. for 24 hours to obtain a reaction product. The reaction product was cooled at room temperature, and 1,2-dichlorobenzene in the reaction product was concentrated. An extraction process was performed thereon three times by using dichloromethane and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:hexane) to synthesize Compound 7 (yield of 43%).
[0525] ESI-LCMS: [M].sup.+: C.sub.80H.sub.66D.sub.8BN.sub.5OPt, 1335.1
Synthesis Example 2: Synthesis of Compound 24
##STR00210## ##STR00211## ##STR00212##
1) Synthesis of Intermediate 24-1
[0526] 4-bromo-6-fluoropyrimidine (1.0 eq), 2-methoxy-6-phenyl-9H-carbazole (2.0 eq), and potassium phosphate (3.0 eq) were dissolved in N,N-dimethylmethanamide (0.01 M) and stirred at 150 C. for 20 hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:hexane) to synthesize Intermediate 24-1 (yield of 87%).
2) Synthesis of Intermediate 24-2
[0527] Intermediate 24-1 (1.0 eq), 3,6-bis(methyl-d.sub.3)-9H-carbazole (1.2 eq), copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and ()-trans-1,2-diaminocyclohexane (0.10 eq) were dissolved in N,N-dimethylformamide (0.01M) and stirred at 150 C. for 24 hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 24-2 (yield of 80%).
3) Synthesis of Intermediate 24-3
[0528] After Intermediate 24-2 (1 eq) was dissolved in ortho dichlorobenzene, the flask was cooled to 0 C. under a nitrogen atmosphere, and BI.sub.3 (3 eq) dissolved in ortho dichlorobenzene was slowly injected thereto. After termination of the dropwise addition, the temperature was raised to 140 C., followed by stirring for 16 hours. After cooling to 0 C., triethylamine was slowly added dropwise to the flask to terminate the reaction until the exotherm stopped, and n-hexane and methanol were added thereto and a solid was subjected to filtration and precipitation. The obtained solid was purified by silica filtration and purified again by MC/Hex recrystallization to obtain Intermediate 24-3. Afterwards, final purification was performed using column (dichloromethane: n-hexane) (yield: 74%).
4) Synthesis of Intermediate 24-4
[0529] After Intermediate 24-3 (1.0 eq) was dissolved in dichloromethane (0.01 M), boron tribromide 1.0M dichloromethane (2 eq) was slowly added thereto at 0 C. under a nitrogen atmosphere. The mixed solution was stirred at room temperature for four hours to obtain a reaction product. An extraction process was performed on the reaction product three times by using water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:Hex) to synthesize Intermediate 24-4 (yield of 66%).
5) Synthesis of Intermediate 24-5
[0530] Intermediate 7-4 (1.0 eq), 1-bromo-3-chlorobenzene (2.0 eq), copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and 2-picolinic acid (0.10 eq) were dissolved in dimethyl sulfoxide (0.01 M) and stirred at 100 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 24-5 (yield of 73%).
6) Synthesis of Intermediate 24-6
[0531] Intermediate 24-5 (1.0 eq), N.sup.1-(5-(tert-butyl)-3,5-bis(methyl-d.sub.3)-[1,1:3,1-terphenyl]-2-yl)benzene-1,2-diamine (1.0 eq), 2-dicyclohexylphosphino-2,4,6-triisopropylbiphenyl (Xphos, 0.10 eq), tris(dibenzylideneacetone)dipalladium(0) (Pd.sub.2(dba).sub.3, 0.05 eq), and sodium tert-butoxide (NaOtBu, 3.0 eq) were dissolved in 1,4-dioxane and stirred at 110 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 24-6 (yield of 85%).
7) Synthesis of Intermediate 24-7
[0532] After Intermediate 24-6 (1.0 eq) was dissolved in triethyl orthoformate (30 eq), 37% HCl (1.5 eq) was added thereto. The mixed solution was stirred at 80 C. for 18 hours to obtain a reaction product. The reaction product was cooled at room temperature, and triethyl orthoformate in the reaction product was concentrated. An extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:methanol) to synthesize Intermediate 24-7 (yield of 79%).
7) Synthesis of Compound 24
[0533] Intermediate 24-7 (1.0 eq), potassium platinum (II) chloride (1.1 eq), and 2,6-lutidine (4.0 eq) were dissolved in 1,2-dichlorobenzene (0.05 M) and stirred under nitrogen conditions at 120 C. for 24 hours to obtain a reaction product. The reaction product was cooled at room temperature, and 1,2-dichlorobenzene in the reaction product was concentrated. An extraction process was performed thereon three times by using dichloromethane and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:hexane) to synthesize Compound 24 (yield of 52%).
[0534] ESI-LCMS: [M]+: C.sub.73H.sub.41D.sub.12BN.sub.6OPt, 1248.2
Synthesis Example 3: Synthesis of Compound 64
##STR00213## ##STR00214## ##STR00215##
1) Synthesis of Intermediate 64-1
[0535] Intermediate 7-1 (1.0 eq), 3,6-bis(methyl-d.sub.3)-9H-carbazole (1.2 eq), copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and ()-trans-1,2-diaminocyclohexane (0.10 eq) were dissolved in N,N-dimethylformamide (0.01M) and stirred at 150 C. for 24 hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 64-2 (yield of 84%).
2) Synthesis of Intermediate 64-2
[0536] After Intermediate 64-1 (1 eq) was dissolved in ortho dichlorobenzene, the flask was cooled to 0 C. under a nitrogen atmosphere, and BI.sub.3 (3 eq) dissolved in ortho dichlorobenzene was slowly injected thereto. After termination of the dropwise addition, the temperature was raised to 140 C., followed by stirring for 16 hours. After cooling to 0 C., triethylamine was slowly added dropwise to the flask to terminate the reaction until the exotherm stopped, and n-hexane and methanol were added thereto and a solid was subjected to filtration and precipitation. The obtained solid was purified by silica filtration and purified again by MC/Hex recrystallization to obtain Intermediate 64-2. Afterwards, final purification was performed using column (dichloromethane: n-hexane) (yield: 76%).
3) Synthesis of Intermediate 64-3
[0537] After Intermediate 64-3 (1.0 eq) was dissolved in dichloromethane (0.01 M), boron tribromide 1.0M dichloromethane (2 eq) was slowly added thereto at 0 C. under a nitrogen atmosphere. The mixed solution was stirred at room temperature for four hours to obtain a reaction product. An extraction process was performed on the reaction product three times by using water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:Hex) to synthesize Intermediate 64-3 (yield of 68%).
4) Synthesis of Intermediate 64-4
[0538] Intermediate 64-3 (1.0 eq), 1-bromo-3-chlorobenzene (2.0 eq), copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and 2-picolinic acid (0.10 eq) were dissolved in dimethyl sulfoxide (0.01 M) and stirred at 100 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 64-4 (yield of 65%).
5) Synthesis of Intermediate 64-5
[0539] Intermediate 64-4 (1.0 eq), 12-(tert-butyl)-10-(5-(tert-butyl)-[1,1-biphenyl]-3-yl-2,2,3,4,4,5,6,6-d.sub.8)-9H-tetrabenzo[b,d,f,h]azonin-8-amine (1.0 eq), 2-dicyclohexylphosphino-2,4,6-triisopropylbiphenyl (Xphos, 0.10 eq), tris(dibenzylideneacetone)dipalladium(0) (Pd.sub.2(dba).sub.3, 0.05 eq), and sodium tert-butoxide (NaOtBu, 3.0 eq) were dissolved in 1,4-dioxane and stirred at 110 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 64-5 (yield of 88%).
6) Synthesis of Intermediate 64-6
[0540] After Intermediate 64-5 (1.0 eq) was dissolved in triethyl orthoformate (30 eq), 37% HCl (1.5 eq) was added thereto. The mixed solution was stirred at 80 C. for 18 hours to obtain a reaction product. The reaction product was cooled at room temperature, and triethyl orthoformate in the reaction product was concentrated. An extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:methanol) to synthesize Intermediate 64-6 (yield of 81%).
7) Synthesis of Compound 64
[0541] Intermediate 64-6 (1.0 eq), potassium platinum (II) chloride (1.1 eq), and 2,6-lutidine (4.0 eq) were dissolved in 1,2-dichlorobenzene (0.05 M) and stirred under nitrogen conditions at 120 C. for 24 hours to obtain a reaction product. The reaction product was cooled at room temperature, and 1,2-dichlorobenzene in the reaction product was concentrated. An extraction process was performed thereon three times by using dichloromethane and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:hexane) to synthesize Compound 64 (yield of 57%).
[0542] ESI-LCMS: [M]+: C.sub.82H43D.sub.17BN.sub.5OPt, 1254.1
Synthesis Example 4: Synthesis of Compound 90
##STR00216## ##STR00217## ##STR00218##
1) Synthesis of Intermediate 90-1
[0543] 4-bromo-6-fluoropyrimidine (1.0 eq), 2-methoxy-9H-carbazole-5,6,7,8-d.sub.4 (2.0 eq), and potassium phosphate (3.0 eq) were dissolved in N,N-dimethylmethanamide (0.01 M) and stirred at 150 C. for 20 hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:hexane) to synthesize Intermediate 90-1 (yield of 82%).
2) Synthesis of Intermediate 90-2
[0544] Intermediate 90-1 (1.0 eq), 9H-carbazole-1,2,3,4,5,6,7,8-d.sub.8 (1.2 eq), copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and ()-trans-1,2-diaminocyclohexane (0.10 eq) were dissolved in N,N-dimethylformamide (0.01M) and stirred at 150 C. for 24 hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 90-2 (yield of 84%).
3) Synthesis of Intermediate 90-3
[0545] After Intermediate 90-2 (1 eq) was dissolved in ortho dichlorobenzene, the flask was cooled to 0 C. under a nitrogen atmosphere, and BI.sub.3 (3 eq) dissolved in ortho dichlorobenzene was slowly injected thereto. After termination of the dropwise addition, the temperature was raised to 140 C., followed by stirring for 16 hours. After cooling to 0 C., triethylamine was slowly added dropwise to the flask to terminate the reaction until the exotherm stopped, and n-hexane and methanol were added thereto and a solid was subjected to filtration and precipitation. The obtained solid was purified by silica filtration and purified again by MC/Hex recrystallization to obtain Intermediate 90-3. Afterwards, final purification was performed using column (dichloromethane:n-hexane) (yield: 76%).
4) Synthesis of Intermediate 90-4
[0546] After Intermediate 90-3 (1.0 eq) was dissolved in dichloromethane (0.01 M), boron tribromide 1.0M dichloromethane (2 eq) was slowly added thereto at 0 C. under a nitrogen atmosphere. The mixed solution was stirred at room temperature for four hours to obtain a reaction product. An extraction process was performed on the reaction product three times by using water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:Hex) to synthesize Intermediate 90-4 (yield of 89%).
5) Synthesis of Intermediate 90-5
[0547] Intermediate 90-4 (1.0 eq), 2-bromo-4-chloro-1-(methyl-d.sub.3)benzene (2.0 eq), copper(I) iodide (0.05 eq), potassium carbonate (3.0 eq), and 2-picolinic acid (0.10 eq) were dissolved in dimethyl sulfoxide (0.01M) and stirred at 100 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 90-5 (yield of 68%).
6) Synthesis of Intermediate 90-6
[0548] Intermediate 90-5 (1.0 eq), 10-(3,5-bis(methyl-d.sub.3)phenyl-2,4,6-d.sub.3)-12-(tert-butyl)-9H-tetrabenzo[b,d,f,h]azonin-8-amine (1.0 eq), 2-dicyclohexylphosphino-2,4,6-triisopropylbiphenyl (Xphos, 0.10 eq), tris(dibenzylideneacetone)dipalladium(0) (Pd.sub.2(dba).sub.3, 0.05 eq), and sodium tert-butoxide (NaOtBu, 3.0 eq) were dissolved in 1,4-dioxane and stirred at 110 C. for two hours to obtain a reaction product. After cooling the reaction product at room temperature, the solvent was removed therefrom by distillation under reduced pressure at 8 mbar, and an extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC/Hex) to synthesize Intermediate 90-6 (yield of 82%).
7) Synthesis of Intermediate 90-7
[0549] After Intermediate 90-6 (1.0 eq) was dissolved in triethyl orthoformate (30 eq), 37% HCl (1.5 eq) was added thereto. The mixed solution was stirred at 80 C. for 18 hours to obtain a reaction product. The reaction product was cooled at room temperature, and triethyl orthoformate in the reaction product was concentrated. An extraction process was performed thereon three times by using MC and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:methanol) to synthesize Intermediate 90-7 (yield of 78%).
7) Synthesis of Compound 90
[0550] Intermediate 90-7 (1.0 eq), potassium platinum (II) chloride (1.1 eq), and 2,6-lutidine (4.0 eq) were dissolved in 1,2-dichlorobenzene (0.05 M) and stirred under nitrogen conditions at 120 C. for 24 hours to obtain a reaction product. The reaction product was cooled at room temperature, and 1,2-dichlorobenzene in the reaction product was concentrated. An extraction process was performed thereon three times by using dichloromethane and water to obtain an organic layer. The organic layer thus obtained was dried with magnesium sulfate, concentrated, and subjected to column chromatography (MC:hexane) to synthesize Compound 90 (yield of 57%).
[0551] ESI-LCMS: [M]+: C.sub.72H27D.sub.22BN.sub.6OPt, 1241.9
Evaluation Example 1: Evaluation of Characteristics of Organometallic Compound
[0552] For the compounds synthesized in Synthesis Examples 1 to 4, liquid chromatography mass (LC-MS) was measured, and results thereof are shown in Table 1. The twist angles of the compounds synthesized in Synthesis Examples 1 to 4 are shown in Table 2.
[0553] As shown in Reference Compound X, three arbitrary points may be marked to the left and right with Pt as the center to provide the appearance of triangular faces, and when this is schematized one-dimensionally as shown in the diagram of Reference Compound X, a quadrangle may be obtained. The face angle (or the twist angle) may be obtained from the quadrangle. (The three-dimensional structure was calculated by using a DFT method of Gaussian program structurally optimized at a level of B3LYP/6-311G(d,p).)
##STR00219##
[0554] Synthesis methods of compounds other than the compounds synthesized in Synthesis Examples 1 to 4 may be easily recognized by those skilled in the art by referring to the synthesis paths and source materials.
TABLE-US-00001 TABLE 1 LC-MS (m/z) [M.sup.+] Compound No. Calculated Measured Compound 7 1334.61 1335.1 Compound 24 1247.48 1248.2 Compound 64 1353.56 1254.1 Compound 90 1241.51 1241.9
[0555] The final compounds from Table 1 were further purified to final purity by sublimation purification, and the obtained compounds were identified as Compounds 7, 24, 64, and 90 by ESI-LCMS.
TABLE-US-00002 TABLE 2 Compound No. Diagram Twist angle [] Reference Compound X
[0556] From Table 2, it could be confirmed that each of Compounds 7, 24, 64, and 90 had an appropriate twist angle in a range of 20 degrees to 40 degrees. Therefore, Compounds 7, 24, 64, and 90 may have excellent material stability due to a skeletal structure that is neither excessively distorted nor excessively flat.
Example 1
[0557] As an anode, a glass substrate with 15 /cm.sup.2 (1,200 ) ITO formed thereon was cut to a size of 50 mm50 mm0.7 mm, sonicated with isopropyl alcohol and pure water each for 5 minutes, and cleaned by irradiation of ultraviolet rays and exposure of ozone thereto for 30 minutes. The resultant glass substrate was loaded onto a vacuum deposition apparatus.
[0558] 2-TNATA was vacuum-deposited on the anode to form a hole injection layer having a thickness of 600 , and NPB was vacuum-deposited on the hole injection layer to form a hole transport layer having a thickness of 300 .
[0559] Compound 7 (15 wt % based on emission layer) as a phosphorescent sensitizer, DFD29 (1.2 wt % based on emission layer) as a TADF material, and a mixed host of HTH15 and ETH2 (at a weight ratio of 6.5:3.5) were co-deposited on the hole transport layer to form an emission layer having a thickness of 350 .
[0560] HBL-1 was vacuum-deposited on the emission layer to form a hole blocking layer having a thickness of 50 . A mixed layer of CNNPTRZ and LiQ (at a weight ratio of 4.0:6.0) was deposited on the hole blocking layer to form an electron transport layer having a thickness of 310 . Yb was deposited on the electron transport layer to form an electron injection layer having a thickness of 15 , and Mg was vacuum-deposited on the electron injection layer to form a cathode electrode having a thickness of 800 , thereby completing the manufacture of a light-emitting device.
##STR00225## ##STR00226## ##STR00227##
Examples 2 to 4 and Comparative Examples 1 to 3
[0561] Light-emitting devices were manufactured in the same manner as in Example 1, except that compounds shown in Table 3 were each used as a phosphorescent sensitizer to form an emission layer.
Examples 5 to 8 and Comparative Examples 4 to 6
[0562] Light-emitting devices were manufactured in the same manner as in Example 1, except that for each of an exciplex host, a phosphorescent sensitizer, and a TADF material, compounds shown in Table 4 were used in a ratio (a weight ratio based on emission layer) shown in Table 4 to form an emission layer.
Evaluation Example 2: Evaluation of Characteristics of Light-Emitting Device
[0563] The driving voltage, luminescence efficiency, maximum emission wavelength, and lifespan (T.sub.95) of each of the light-emitting devices manufactured in Examples 1 to 4 and Comparative Examples 1 to 3 were each measured at 1,000 cd/m.sup.2 using Keithley MU 236 and luminance meter PR650, and results thereof are shown in Table 3. In Table 3, the lifespan (T.sub.95) is a measure of the time (hr) for the luminance to reach 95% of the initial luminance.
[0564] The driving voltage, luminescence efficiency, maximum emission wavelength, and lifespan (T.sub.95) of each of the light-emitting devices manufactured in Examples 5 to 8 and Comparative Examples 4 to 6 were each measured at 1,000 cd/m.sup.2 using Keithley MU 236 and luminance meter PR650, and results thereof are shown in Table 4. In Table 4, the lifespan (T.sub.95) is a measure of the time (hr) for the luminance to reach 95% of the initial luminance.
TABLE-US-00003 TABLE 3 Exciplex host Driving Luminescence Maximum Lifespan (HT:ET= Phosphorescent TADF voltage Efficiency emission ratio 6.5:3.5) sensitizer material [V] [Cd/A] wavelength (T.sub.95) Example 1 HTH15: Compound 7 DFD29 4.21 18.6 Blue 530 ETH2 (15 wt %) (1.2 wt %) Example 2 HTH15: Compound 24 DFD29 4.15 17.9 Blue 551 ETH2 (15 wt %) (1.2 wt %) Example 3 HTH15: Compound 64 DFD29 4.10 18.9 Blue 524 ETH2 (15 wt %) (1.2 wt %) Example 4 HTH15: Compound 90 DFD29 4.23 17.6 Blue 512 ETH2 (15 wt %) (1.2 wt %) Comparative HTH15: Compound A DFD29 4.45 12.4 Blue 210 Example 1 ETH2 (15 wt %) (1.2 wt %) Comparative HTH15: Compound B DFD29 4.59 10.8 Blue 167 Example 2 ETH2 (15 wt %) (1.2 wt %) Comparative HTH15: Compound C DFD29 4.57 8.7 Blue ref Example 3 ETH2 (15 wt %) (1.2 wt %) 100
[0565] From Table 3, it was confirmed that the light-emitting devices according to Examples 1 to 4 had lower driving voltage, higher luminescence efficiency, and longer lifespan, compared to the light-emitting devices according to Comparative Examples 1 to 3.
TABLE-US-00004 TABLE 4 Exciplex host Driving Luminescence Maximum Lifespan (HT:ET = Phosphorescent TADF voltage efficiency emission ratio 6.5:3.5) sensitizer material [V] [Cd/A] wavelength (T.sub.95) Example 5 HTH15:ETH17 Compound 7 DFD7 4.33 16.8 Blue 483 (12 wt %) (0.8 wt %) Example 6 HTH15:ETH17 Compound 24 DFD7 4.26 18.1 Blue 477 (12 wt %) (0.8 wt %) Example 7 HTH15:ETH17 Compound 64 DFD7 4.25 17.3 Blue 465 (12 wt %) (0.8 wt %) Example 8 HTH15:ETH17 Compound 90 DFD7 4.31 18.4 Blue 489 (12 wt %) (0.8 wt %) Comparative HTH15:ETH17 Compound A DFD7 4.58 15.7 Blue 186 Example 4 (12 wt %) (0.8 wt %) Comparative HTH15:ETH17 Compound B DFD7 4.65 11.2 Blue 153 Example 5 (12 wt %) (0.8 wt %) Comparative HTH15:ETH17 Compound C DFD7 4.61 9.2 Blue ref 100 Example 6 (12 wt %) (0.8 wt %)
[0566] From Table 4, it was confirmed that the light-emitting devices according to Examples 5 to 8 had lower driving voltage, higher luminescence efficiency, and longer lifespan, compared to the light-emitting devices according to Comparative Examples 4 to 6.
[0567] A light-emitting device that includes the organometallic compound according to the disclosure may have a low driving voltage, a high efficiency, and a long lifespan. A high-quality electronic apparatus and high-quality electronic equipment may be manufactured using the light-emitting device.
[0568] Embodiments have been disclosed herein, and although terms are employed, they are used and are to be interpreted in a generic and descriptive sense only and not for purposes of limitation. In some instances, as would be apparent by one of ordinary skill in the art, features, characteristics, and/or elements described in connection with an embodiment may be used singly or in combination with features, characteristics, and/or elements described in connection with other embodiments unless otherwise specifically indicated. Accordingly, it will be understood by those of ordinary skill in the art that various changes in form and details may be made without departing from the spirit and scope of the disclosure.